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Gold catalysis has emerged over the past decade as an important 
methodology in the construction of organic molecules. Cationic gold complexes 
are robust, versatile, selective and efficient catalysts that can be used to enhance 
the electrophilicity of C-C unsaturated bonds. A current area of investigation is the 
use of gold to activate allylic alcohol/ether moieties for intramolecular SN2’ 
nucleophilic attack to form oxygen heterocycles. We have discovered that sterically 
bulky, electron-withdrawing oxygen leaving groups drastically improved reaction 
efficiency, and bulky leaving groups in combination with substrate substituents 
enhanced diastereomeric ratios in the oxygen heterocycle products. These 
reactions proceeded smoothly in the presence of many functional groups to 
consistently afford high diastereoselectivity. This methodology was attempted in 
the synthesis complex spirocyclic ether structures, and used in progress towards 
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1. Introduction 
1.1. General Considerations in Gold-Catalysis 
The development of homogeneous organometallic catalysis in organic 
synthesis has allowed access to more complex structures under mild and efficient 
reaction conditions. A famous example was the discovery of palladium-catalyzed 
coupling reactions in the mid 1970’s by Richard F. Heck1 and Tsunomu Mizoroki.2 
Precious metal catalysts like palladium, ruthenium, rhodium and platinum have 
been extensively investigated in synthetic methodology, however the study of gold 
catalysis began relatively late in comparison. 
A few applications of gold catalysis were described in the 1990’s,3 however 
the organometallic “gold rush” occurred in the first decade of the 21st century with 
the development of phosphine and carbene ligands to form stable gold catalyst 
salts. The introduction of these gold catalysts instigated a marked increase in the 
number of publications on the topic of gold catalysis with the greatest number of 
publications occurring in the most recent year of 2014 with 1,060 publications 
(Figure 1-1).4,5  
In comparison to other precious metals catalysts used in organic chemistry, 
gold salts are relatively affordable in cost per mole even though elemental gold 
metal is one of the most expensive metals (Table 1-1).6,7 There are several factors 
that influence the price of catalyst including the complexity of the ligand, the 
sensitivity, and the demand.8 Additionally, the impressive reactivity and robustness 
of gold catalysts allow for potentially lower catalytic loadings with higher turn-over 





Figure 1-1. Number of publications on the topic of gold catalysis from 1980-2015. 
Table 1-1. Elemental and cationic salt price/mmol of precious metals as of 
September 2014. 
Metal Price/mmol in 
US $ 
Catalyst Form Price/mmol in 
US $ 
Gold 7.74 AuCl / AuCl
3
  52.88/57.63 
Iridium 3.77 IrCl
3
  72.55 
Osmium 2.32 OsCl
3
  195.24 
Palladium 2.80 PdCl
2
  9.40 
Platinum 8.37 PtCl
2 / PtCl4  66.23/63.50 
Rhenium 4.52 ReCl
3
  96.26 
Rhodium 4.47 RhCl
3
  65.71 
Ruthenium 0.21 RuCl
3
  10.25 































Gold exists in several oxidation states, the most prevalent of which are 
Au(0), Au(I), and Au(III). Au(I) has been intensively studied in catalysis due to its 
low oxidation state and linear coordination geometry.9,10 Au(I) catalysts are stable 
in the presence of a large number of functional groups, and have a simple 
geometry in ligand design. However, in the absence of stabilizing ligands, Au(I) 
under goes a rapid disproportionation reaction into Au(0) and Au(III). 11  Many 
commercially available water- and air-stable gold complexes have been 
synthesized to overcome the limitations associated with this reactivity as shown in 
Figure 1-2.4 
 
Figure 1-2. Commercially available Au(I) catalysts. 
Though these ligands significantly reduce the disproportionation reaction of 
Au(I), this side reaction has been observed despite the presence of stabilizing 
ligands. Vyvyan and co-workers observed the disproportionation of 1-2 in a Claisen 
rearrangement of allyl aryl ethers.12 The synthetic community has assumed this 
disproportionation leads to decreased catalytic activity and increased side 
reactions as Au(0) precipitates out of solution, and Au(III) is considered less stable 
  
4 
to functional groups in catalysis.13,14,15 Contrary to this belief, Au(III) was the 
catalytically active species in the reported Claisen rearrangement.  
Gold(III) cationic complexes have been poorly investigated, largely because 
the scientific community has been focused on reaction methodologies involving 
Au(I) cationic complexes due to the simplicity of ligand design for these linear 
bicoordinate complexes, and the mild reaction conditions of this low oxidation state 
Lewis acid.15 However, there are some potential advantages to Au(III) complexes. 
First, the higher oxidation state of this gold complex makes it more electrophilic 
and oxophilic, which could indicate increased reactivity in the activation of π-
systems by increasing the delocalization of electrons. Second, the tetracoordinate, 
square planar coordination geometry of Au(III) complexes allows for greater ability 
to tune cationic complexes through bi- or tri-dentate ligand design, and increased 
steric bulk near the reaction center may influence diastereoselective and 
enantioselective reactions. The work to be presented in this thesis focuses on the 
increased reactivity of Au(III), and commercially available ligands that allow for 
stereoselective transformations. 
Gold was not considered for investigation in the early days of organometallic 
catalysis due to its lack of reactivity in its elemental form. The resistance of metallic 
gold to oxidation was believed to correspond to a diminished or absent reactivity 
as a cationic catalyst. The conditions needed to oxidize gold support this 
hypothesis; an extremely caustic mixture of hydrochloric acid and nitric acid, 
known as aqua regia (latin for “regal water”), is required to form cationic gold salts. 
The unusual lack of reactivity of gold metal is orthogonal to the surprisingly 
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powerful reactivity of cationic gold in a broad range of organic transformations. 
These interesting effects of gold are closely related to relativistic effects. In 
computational analysis of the relativistic and non-relativistic 6s orbital radii it was 
observed gold exhibits the largest relativistic effects among the elements (Figure 
1-3).16  
 
Figure 1-3. The relativistic and non-relativistic 6s orbital radii. (Reprinted from ref. 
12) 
The relativistic effects observed in gold provide a theoretical framework for 
rationalizing observed reactivity as well as proposing potential hypothetical 
reactivity. The experimentally observed characteristics of cationic gold complexes 
may be theoretically described by the contraction of the 6s orbital and expansion 
of the 5d orbitals. This relativistic orbital interaction explains the observed yellow 
hue of gold metal. The highest occupied molecular orbital (HOMO) and lowest 
unoccupied molecular orbital (LUMO) are sufficiently close in energy due to 
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relativistic effects that the highest energy of visible light (blue) will be absorbed to 
allow an excitation of an electron from the HOMO to the LUMO, and thereby reflect 
all remaining light from the spectrum to give a yellow hue. 
Additionally, the atomic radius of gold (144 pm) is significantly decreased 
and is comparable to the size of silver (144 pm) (Figure 1-3).17 This relativistic 
contraction results in tighter binding energy of the s electrons. This makes the 
cohesive metallic bonds much more difficult to oxidize, and gold cationic species 
exceptional Lewis acids.  
 
Figure 1-3. Relativistic effects in gold. 
 
1.2. Gold-Catalyzed Addition to π-Systems 
 
Gold(I) and gold(III) species are both Lewis acids with an affinity for π-bonds, 
and have the ability to activate soft electrophiles such as C-C double and triple 
bonds. The strong Lewis acidity of gold is due to the relative low energy of the 
lowest unoccupied molecular orbital (LUMO). This makes cationic gold species 
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ideal catalysts for the mild activation of π-systems. Additionally, since they are 
Lewis acids, these catalysts have access to a large selection of commercial 
available ligands through coordination of Lewis bases observed in phosphorous 
and nitrogen ligands which may be used to tune the electronic and steric 
environment of the coordination sphere. Finally, cationic gold delocalizes electrons, 
and stabilizes electrophiles through the strong back-bonding character of this atom. 
The relativistic expansion of the 5d orbitals in gold increases the back bonding 
effect and therefore facilitates electron delocalization.5 
 
1. 3. Gold-Catalyzed Activation of Alkynes 
The first and most widely investigated methodology concerning gold 
catalysis has been the activation of alkynes. Gold cationic complexes behave as 
chemoselective π-acids to remove electron density and promote electrophilic 
character, which can then be attacked by a nucleophile. 
This synthetic methodology has been utilized in many examples for the mild 
activation of alkynes with cationic gold species. In 2004, Arcadi and co-workers 
used a cationic gold complex to activate an alkyne for intramolecular nucleophile 
attack on aniline 1-5 to form indole 1-6 in high yield and efficient reaction time 
(Scheme 1-1).18 An excellent example of the robustness and reactivity of gold 
catalyst was the intermolecular addition to an alkyne reported by Nolan and co-
workers in which they were able to use 0.01 mol% of catalyst in the hydration of 
alkyne 1-7 to obtain ketone 1-8 in high yield using water as a co-solvent and 
nucleophile. 19  Additionally, cationic gold complexes may be utilized in mild 
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activation of otherwise unreactive π-systems. Hashmi investigated the synthesis 
of hydroxyl-substituted isoindolines from a furan catalyzed by Au(III) chloride in a 
Diels-Alder reaction.20 In this reaction the cationic gold species first activates the 
terminal alkyne of 1-9 for intramolecular Diels-Alder reaction with the relatively 
unreactive furan diene.21 The oxophilic Au(III) chloride mediates scission of the 
oxygen bridge, and the restoration of aromaticity to afford isoindoline 1-12 in 97% 
yield.  
 





Trost and co-workers utilized an intramolecular gold-catalyzed alkoxylation 
of an alkyne to form a tetrahydropyran in a late stage in the total synthesis of the 
complex natural product, Bryostatin 16 (Equation 1-1). This is an excellent use of 
Au(I) in the activation of an alkyne to afford the corresponding tetrahydropyran in 
73% yield without side reactions or decreased reactivity in the presence of many 





1.4. Gold-Catalyzed Activation of Allenes 
The ability to activate alkynes with cationic gold species has attracted the 
interest of many other groups towards the activation of other reactive π-bonds like 
allenes. In 2006, Widenhoefer and co-workers investigated the gold catalyzed 
cyclization of allene 1-15 to form tetrahydropyran 1-16 in high yield and moderate 
diastereomeric ratios (Scheme 1-2). 23  Shortly after, in 2008, Widenhoefer 
observed the intermolecular hydroamination of allene 1-18 in good yield at room 
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temperature.24 In 2007, an electrophilic aromatic substitution was used by Ohno 
and co-workers to synthesize dihydroquinoline 1-21 from allenic aniline 1-20 in 
92% yield in 5 minutes at room temperature.25 
 
Scheme 1-2. Selected examples of gold catalyzed activation of allenes. 
 
The advantage of utilizing allenes as electrophiles in synthesis is the ability 
to form a stereogenic center by stereoselective activation.26 Chiral bisphopshine 
ligands26 and phosphate counterions27 have attracted significant interest for their 
ability to be synthesized from readily available sterically bulky, axially chiral 
binapthalene derivatives. These privileged chiral resolving agents have been 
investigated thoroughly by several groups in enantioselective gold catalyzed 
reactions, and have proven to be efficient stereoselective ligands in synthesis.28 
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Toste has published many examples of enantioselective gold-catalyzed 
reactions. In 2007, his group used a chiral phosphine ligand-based gold catalyst in 
the enantioselective intramolecular hydroamination of allenes in which they were 
able to obtain pyrolidine 1-23 in quantitative yield and 99% enantiomeric excess 
(Scheme 1-3). 29  Due to the linear bi-coordinate geometry of Au(I), low 
enantioselectivity is often observed because the steric bulk of the ligand is located 
relatively far from the reaction center.18  
Toste and co-workers hypothesized that chiral information may be moved 
closer to the reaction center by utilizing a chiral anion to associate near the 
electrophilic cation formed when the gold complex activates the substrate for 
nucleophilic attack. This group observed exceptional enantioselectivity in the Au(I) 
catalyzed hydroalkoxylation of allene 1-25 when they used chiral counter ion silver 
salt 1-27 in a non-polar solvent.30  
Though gold-catalyzed reactions have seen significant success in the 
activation of alkynes and allenes, this methodology is limited in the activation of 
alkenes. Several examples have been reported in literature, but unlike other 
palladium and platinum activation of alkenes, gold has required increased 
temperatures to promote electrophilic activation. He and co-workers found 85 °C 
was required to perform the gold-catalyzed addition of phenol to an alkene in 84% 









1.4. Metal-Catalyzed Activation of Unsaturated Alcohols 
Unsaturated alcohols are ubiquitous, readily synthesized intermediates in 
organic chemistry. Transformations involving these functional groups under 
Brønsted or Lewis acidic conditions have been extensively investigated. Metal 
catalyzed activation of allylic, propargylic and benzylic alcohols have broad utility 
in organic synthesis and many reports have general applicability towards the use 
in gold catalysis.32-42  
Allylic alcohols or ethers can be synthesized by reduction of propargylic 
alcohols, reduction of α,β-unsaturated carbonyls, or olefin metathesis with allylic 
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alcohols or ethers. These allylic alcohol moieties can act as surrogates for allenes 
with similar reactivity, greater stability and simple preparation. Metal activation of 
allylic acohols has been investigated, but the catalytic loadings remain relatively 
high in comparison to alkynes and allenes, and require higher temperatures or 
longer reaction times. 
Several examples in the literature suggest the potential for these functional 
groups to allow for electrophilic activation with Lewis acid catalysis.32-42 Uenishi 
and co-workers demonstrated a highly efficient Pd(II)-catalyzed intramolecular 
cyclization for the formation – from chiral allylic alcohols – to afford 
tetrahydropyrans like 1-32 containing tetrasubstituted stereocenters. This reaction 
proceeded stereospecifically by 1,3-chirality transfer through a syn-SN2 process to 
afford 2,2,6-trisubstituted tetrahydropyrans and spirohydropyrans in high yields 
(Scheme 1-4).32  However, excessively high catalytic loading (30 mol %) was 
required for this reaction. Ruthenium(I)-catalyzed intermolecular Friedel-Crafts 
reactions have been reported by Wörle and co-workers which afforded 3-
substituted indoles 1-35 in quantitative yields.33 This reaction required the use of 
camphorsulfonic acid as a co-catalyst. Mashima and co-workers used 1 mol % of 
a platinum(II) catalyst in the activation of allylic alcohol 1-37 for  addition of aniline 
1-36. Though the catalyst loading was low (1 mol%),  the reaction required high 





Scheme 1-4. Selected examples of metal catalyzed activation of allylic alcohols. 
 
Propargyl alcohols are versatile and useful intermediates in organic 
synthesis. Activation of these electrophiles with an alcohol leaving group allows for 
powerful transformations allowing access to numerous types of functional groups 
by altering reaction conditions.35 Due to their increased electron density these 
functional groups have been utilized in complex cascade reactions, and multi-step, 
one-pot procedures. Propargylic alcohols activated by metal salts are often used 
to form 5-membered heterocycles.36 In 2009, Aponick and co-workers developed 
a synthesis of furans, pyrroles and thiophenes by gold-catalyzed activation of 
propargyl alcohols.37 An excellent example from this work demonstrated the use 
of as little as 0.05 mol% of catalyst to convert a propargyl alcohol 1-39 into furan 
1-40 in 92% yield in only 15 minutes (Scheme 1-5). An interesting intermolecular 
reaction to form furan 1-43 in modest yield from readily available aryl boronic acid 
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1-41, propargyl alcohol 1-42 and carbon monoxide under low rhodium(I) catalyst 
loading was reported in 2010 by Castanet and co-workers.38  
 
Scheme 1-5. Selected examples of metal catalyzed activation of propargylic 
alcohols. 
 
Aponick and co-workers have recently reported on gold-catalyzed reactions 
of propargyl alcohols to form complex heterocyclic structures. This group 
developed a novel approach to unsaturated spiroketal structures that addresses 
the regioselectivity issues commonly reported in metal-catalyzed spiroketalization 
of alkynes.39  The reaction sequence is regulated by the use of an acetonide 
protecting group in 1-44, which in the process of the reaction undergoes extrusion 
of acetone to deliver a broad range of spiroketals like 1-44 in good yields and 
diastereoselectivities (Scheme 1-6). Aponick’s group has also described the 
synthesis of cyclic 2-oxodienes from propargyl alcohols, which can be used in a 
subsequent Diels-Alder reaction.40 The dehydrative cyclization reaction proceeds 
smoothly with 5 mol % catalyst in 5 minutes. The subsequent diene readily 
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underwent a cycloaddition in-situ with a variety of dienophiles. This method 
allowed for a new strategy to synthesize indolocarbazole alkaloids. 
 
Scheme 1-6. Complex structures formed by Au(I) catalyzed activation of propargyl 
alcohols. 
 
Ionization of benzylic alcohols under mild acidic conditions has also been 
extensively investigated. The resonance-stabilized cation formed after the loss of 
water may be reacted with any nucleophile, usually through an SN1 mechanism. 
This allows access to many carbon-carbon and carbon-heteroatom bonds. In 2006, 
Campagne and co-workers utilized this reactivity by activation of benzylic alcohols 
with 5 mol % of various Lewis acids in the nucleophilic substitution with tosylamine 
(Scheme 1-7).41 Of all the Lewis acids tested, Au(III) cationic salt proved to be the 
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best catalyst, and the use of organic acids gave poor yields and side products. 
This type of transformation has also been used in Michael style addition with β-
ketoesters.42 This reaction worked well in the presence of various Lewis acids 
though the catalyst loading was high. 
 
Scheme 1-7. Selected examples of Lewis acid activation of benzylic alcohols. 
 
The facile synthesis, and Lewis acid activation under mild conditions of 
unsaturated alcohols makes these intermediates attractive substrates for 
investigation. Allylic alcohols, however, are less reactive and more difficult to 
activate under mild conditions but are much more accessible and versatile 
intermediates in organic synthesis. Cationic gold complexes have shown 
promising reactivity in this field, and activation of these systems for intramolecular 




2. Metal-Catalyzed Cyclizations to Form Saturated Oxygen Heterocycles  
2.1. Saturated Oxygen Heterocycles in Natural Products 
Saturated oxygen heterocycles are ubiquitous structural motifs in 
biologically active natural products. The prevalence of these functional groups in 
synthetic targets with potent biological activities make them important structural 
components that have attracted the interest of the synthetic community.43  
 
Figure 2-1. Selected examples of natural products containing saturated oxygen 
heterocycles. 
There are several natural products with complex saturated oxygen 
heterocycle structural motifs with excellent biological activity. Spirastrellolide A 2-
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1, extracted from marine sponge Spirastrella coccine, is potent inhibitor of protein 
phosphatase 2. 44  This compound has spiroketal and bis-spiroketal structural 
features which are difficult functional groups to synthesize, but are essential for the 
activity of the molecule. Bryostatins are a group of macrolactones isolated from 
Bugula neritina, a species of bryozoan.45 These architecturally complex organic 
structures are potent modulators of protein kinase C, and have demonstrated 
promising activities against cancer, HIV and Alzheimers.46 An important feature of 
this molecule is the joined tetrahydropyran rings which form the structural manifold 
of this compound. Sorangicin A contains a characteristic dioxabicyclo[3.2.1]octane 
skeleton functionality.47 This macrolide was isolated from myxobacteria Sorangium 
cellulosum and has demonstrated remarkable antibiotic activity against of broad 
spectrum of gram-positive and gram-negative bacteria, as well in the treatment of 
solid tumors resistant to alternative treatments (i.e., Taxol).48  Brevetoxins are a 
class of marine ladder toxins produced by Karenia brevis, a marine dinoflagellate 
found in the Gulf of Mexico, known to be responsible for oceanic red tide.49 These 
compounds bind to the voltage-gated sodium channels in nerve cells and disrupt 
the central nervous system. The complex cyclic polyether structure is exceedingly 
difficult to synthesize due to the ten fused oxygen heterocycles. Traditional 
approaches to the synthesis of cyclic ethers are efficient, but are limited in the 
application to complex chiral structures.50 Metal based catalysis has proven to be 
a powerful synthetic tool to achieve high yield and stereoselectivity through the use 




2.2. Transition Metal-Catalyzed Activation of Alkenes 
The synthetic community has long recognized the power of metal-catalyzed 
intramolecular reactions and continues to expand the scope of these 
methodologies towards the synthesis of saturated oxygen heterocycles. 51 
Contemporary approaches utilize cationic metals as catalysts in the intramolecular 
hydroalkoxylation of unactivated alkenes. Alkenols are readily available, stable 
synthetic intermediates. Coordination of a metal activates the double bond by 
formation of π-complex for nucleophilic addition by an alcohol followed by 
protodemetallation (Scheme 2-1).  
 
Scheme 2-1. General reaction mechanism of metal-catalyzed cyclization of 
alkenol. 
 
In 2004, Widenhoefer and co-workers utilized only 0.5 mol % of platinum 
catalyst in the cyclization of alkenol 2-9 to form a tetrahydropyran 2-10 with 
excellent diastereoselectivity (Scheme 2-2). Though this transformation tolerates 
a large variety of functional groups like pivaloate and acetate esters, amides, silyl 
and benzyl ethers, only moderate yields were reported and high temperatures 
were required.52 This reaction was also investigated by He and co-workers using 
triphenylphosphine silver(I) triflate as a catalyst to obtain the tetrahydropyran 2-12 
in 15 minutes at reflux in dichlorethane.53  
  
21 
Lanthanides have promising activity that has been investigated in this 
methodology, but lanthanide salt-catalyzed processes usually requires toxic, 
highly polar, moderately coordinating solvents.54 Marks and co-workers were able 
to utilize an non-volatile environmentally benign imdizolium-based ionic liquid in 
the hydroalkoxylation using ytterbium(III) triflate to form a benzofuran 2-14.55 
Cationic metal activation of olefins is a practical and efficient methodology in the 
synthesis of cyclic ethers, however harsh conditions including high temperatures 
and long reaction times are often required. 
 
Scheme 2-2. Metal-catalyzed hydroalkoxylation/cyclization of unactivated alkenes. 
 
 
2.3. Transition Metal-Catalyzed Activation of Allylic Alcohols 
Activation of allylic alcohols for inter- and intramolecular substitution reactions has 
been investigated with many different metal-based catalysts. Several mechanisms 
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have been suggested for this type of reaction, which differ based on the metal 
employed in the activation of the allylic alcohol. A syn SN2’ process has been 
reported with Pd(II)56 (Scheme 2-3, A), a π-allyl metal complex formation with 
Pd(0),57 Pt(0),58 Rh(I)59 or Ru(II)60 (Scheme 2-3, B), and stabilized allyl cation with 
Fe(III)61 or Bi(III)62 (Scheme 2-3, C).  
 
Scheme 2-3. Mechanistic pathways in the metal-catalyzed activation of allylic 
alcohols: A) syn SN2’, B) π-allyl metal complex, C) stabilized allyl cation. 
 
In 2010, Cossy and co-workers investigated the iron(III) catalyzed activation 
of a mono-allylic diol 2-15 to form an allyl cation intermediate which intramolecular 
nucleophilic addition allow access to 2,6-disubstituted tetrahydropyrans 2-16 in 
good yield and moderate diastereostereomeric ratios (Scheme 2-4).61 Uenishi and 
co-workers used a palladium(II) catalyst to perform a syn SN2’ cyclization upon the 
allylic alcohol to form a tetrahydropyran 2-18 in 93% yield as a single 
diastereomer.56 Kitamura and co-workers reported the ruthenium(II) catalyzed 
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enantioselective cyclization of mono-allylic diol 2-19 to form tetrahydropyran 2-20 
in 90% yield and 93% ee by utilizing a new chiral ligand 2-21 they developed.60 
Scheme 2-4. Selected examples of metal-catalyzed cyclization of allylic alcohols. 
 
 
2.4. Gold-Catalyzed Activation of Allylic Alcohols 
Prior to 2006, gold was poorly investigated in the activation of allylic 
alcohols, however there are several reports which suggest Au(I) or Au(III) could 
be exceptionally active catalysts in this methodology.1,63 When Au(III) is used to 
activate the allylic alcohol, evidence suggests a allyl stabilized cation is formed 
which may undergo regioisomerization. In 2009, Chan and co-workers 
investigated the Au(III)-catalyzed activation of cinnamyl alcohol 2-22 in an SN1 
nucleophilic substitution with 1,3-diketone 2-21 to afford 2-23 in good yield 
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(Scheme 2-5).64 This same group also described the Au(III)-catalyzed activation 
of phenyl substituted allylic alcohols for electrophilic aromatic substitution with 
arenes and heteroaromatics like 2-26 in good yields.65 Liu and co-workers have 
reported work involving the formation in carbon-heteratom bonds in which they 
described the Au(III)-catalyzed amination of allylic alcohols like 2-28 in good 
yield.66 
 
Scheme 2-5. Selected examples of Au(III) catalyzed activation of allylic alcohols. 
 
These examples represent the reactivity of cationic gold to activate allylic 
alcohols for intermolecular substitution. This methodology has also been applied 
in intramolecular reactions. Previous work completed in the Vyvyan group 
involved the investigation of Au(I)-catalyzed Claisen rearrangement of allyl aryl 
ethers. In this investigation they reported cationic Au(I) and Au(III) catalyzed the 
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reaction of several aryl allyl ethers. However, due to a competing cationic 
pathway Au(I) complexes catalyzed [3,3] and [1,3]-rearrangement products in 
substrates like 2-29 through an ionic mechanism rather than a concerted 
pathway to afford products 2-30, 2-31, and 2-32.67 
Contrary to previously reported information this group discovered 
homogenous Au(III) was an exceptionally active catalyst that preferentially 
favored the intended product 2-30 by progressing through the hypothesized 
concerted [3,3]-rearangment mechanism (Scheme 2-6). Encouraged by these 
results previous group members sought to investigate this reaction further with 
napthol derivatives. Utilizing 10 mol % of Au(OTf)3 formed in situ, they were able 
to produce the single intended rearrangement product in 89% at 0˚C in 6.25 
hours.68 Though the catalyst loading was relatively high, this experiment 
illustrates the potential for homogenous Au(III) complexes to allow for increased 
reactivity while maintaining selectivity in the activation of allylic alcohols. 
Furthermore, researchers were also able to selectively form a cyclized product 2-
34 in 66 % yield when using 10 mol % PPh3PAuOTf.68 Additionally, a researcher 
in this group, Dimmit, found that the same gold catalyst could facilitate the 
formation of a lactone 2-36 from the cyclization of a carboxylic acid-containing 
allylic ether substrate 2-35.12 
These experiments stimulated our interest to utilize the activation of allylic 
alcohols towards the formation of cyclic ethers and lactones. Our initial 
hypothesis was as follows: homogenous Au(III) may allow for increased and 
ligand-diversified reactivity over other metal based methodologies involving the 
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catalytic activation of allylic alcohols towards the intramolecular formation of 
saturated oxygen heterocycles and lactones.  
 
Scheme 2-6. Selected examples Au(I) and Au(III) catalyzed activation of allylic 





3. Synthesis of Lactones 
3.1. Lactones in Natural Products 
Lactones are abundant structural motifs observed in natural products. The 
flowering plant genus Goniothalamus has been a resource for several cytoxic 
acetogenins and styryl-lactones such as cardiopetalolactone 3-1, goniofufurone 3-
2, and annonacin 3-3; all of which incorporate lactones in their molecular 
architectures (Figure 3-1).69 Therefore, facile methodologies to give access to 
these structural features would have broad utility in medicinal chemistry and 
natural product synthesis.70 
 
Figure 3-1. Selected examples of lactone containing natural products.  
Cationic gold complexes have been utilized in the catalytic cyclization to 
synthesize lactones by activation of unsaturated carbon systems. In 2006, Pale 
and co-workers utilized the strong Lewis acidity of Au(I) to activate alkyne 3-4 for 
intramolecular alkoxylation with a carboxylic acid. This reaction allowed access to 
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a myriad of substituted enol lactones like 3-5 in high yield (Scheme 3-1).71 This 
reactivity has also been employed with allylic alcohols. Bandini and co-workers 
utilized Au(I) complexes in the synthesis of functionalized -vinylbutryolactones 
like 3-7 by intramolecular oxaallylic alkylation with primary alcohols like 3-6. This 
group reported good yields obtained for a range of malonyl and acetate 
derivatives.72 
 
Scheme 3-1. Selected examples of Au(I) catalyzed cyclization to form lactones. 
 
In both examples, lactone formation was achieved efficiently with 
inexpensive readily available synthetic intermediates, and mild reaction conditions. 
However, like most gold-catalyzed reactive methodologies, lactone formation has 
primarily focused on Au(I) catalyst systems. Furthermore, electrophilic activation 
of carbon atoms has focused on Au(I) complexation directly with  bonds. As 
previously reported Au(III) is an exceptional catalyst to activate allylic ethers and 
alcohols by complexation with the allylic oxygen and the  bonds to delocalize 
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electrons for nucleophilic attack, and has been relatively unexplored in this 
application.  
3.2. Gold(III)-Catalyzed Cyclization to Form -Butyrolactones 
To test the hypothesis that allylic alcohols and ethers may be activated 
under mild conditions with Au(III) species to form -butryolactones we synthesized 
a substrate for investigation by olefin-metathesis with ethyl pent-4-enoate 3-8 and 
diol 3-9 using Grubbs 2nd generation catalyst (Equation 3-1).  
(3-1) 
Early in our work we had difficulty obtaining the desired cross-metathesis 
product in good yield and purity due to an unintended olefin isomerization to 
produce a complex mixture containing aldehyde 3-11. This undesirable olefin 
isomerization is a known problem in cross-metathesis. Although the mechanism is 
not completely understood it is believed to proceed through a -hydride elimination 




Scheme 3-1. Suggested mechanism of undesired ruthenium catalyzed 
isomerization. 
 
Grubbs and co-workers have reported the phenomenon of undesirable 
isomerization during olefin metathesis, and have also investigated the effect of 
additives on the prevention of this side reaction. Of the additives they tested, p-
benzoquinone was found to prevent olefin isomerization of a number of allylic 
ethers and long-chain aliphatic alkenes during olefin metathesis reactions with a 
ruthenium-based catalysts.73 We utilized this mild, inexpensive, and effective 
additive to inhibit the formation of the aldehyde and improve product yield and 
purity in olefin-metathesis. 
We attempted the cyclization of 3-10 with 10 mol % of catalyst systems 
AuCl3 / 3 AgOTf and Ph3PAuCl / AgOTf. Deuterated chloroform was used as a 
solvent to enable observation of reaction progress by 1H NMR. After 24 hours, the 
reaction had not progressed in either catalyst systems at room temperature 
(Equation 3-2). This result did not improve even with longer reaction times. In an 
effort to keep the reaction conditions mild, we first sought to optimize the substrate 





Toward improving the reactivity of our substrate, we hypothesized a 
mechanism for the reaction based on previously reports of homogenous cationic 
gold catalysis. Due to the oxophilicity of Au(III), we believed it would coordinate to 
the allylic alcohol oxygen and polarize the electrons of the -bond activating the 
system for nucleophilic attack (Scheme 3-2). Therefore, if we were to install an 
electron withdrawing allylic ether it would increase the reactivity of the allylic ether 
system toward nucleophilic attack in the presence of Au(III). Additionally, we 
hypothesized that installation of an electron donating substituent for the ester could 
increase electron density on the carbonyl oxygen, which would increase the 
nucleophilicity of this atom in the reaction. To test this hypothesis we envisioned 
several electron withdrawing substituents we could install to form an allylic ether, 
and several electron donating substituents to install to form the ester. 
 
Scheme 3-2. Purported mechanism Au(III) catalyzed activation of allylic ethers to 
form -butyrolactones. 
 
We synthesized a t-butyl ester substrate by reaction of t-butyl alcohol 3-14 
with acid chloride 3-13 to form ester 3-15 (Scheme 3-3). The poor yield observed 
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in this esterification was a result of water in the t-butyl alcohol and the elimination 
reaction to form isobutene. Olefin metathesis with diol 3-2 afforded substrate 3-16, 
which upon reaction with the gold catalyst systems again afforded less than 10% 
of product as determined by 1H NMR analysis. The isolated yields were not able 
to be determined due to the high volatility of the product. Therefore, all reported 
yields are relative conversion determined by 1H NMR analysis. Though this yield 
is low, we were encouraged that some product was formed. 
We then hypothesized that the electron donating benzyl ester group with 
the ability to from a stable tropylium cation would be an exceptional electron 
donating substituent in this methodology. In order to synthesize intermediate 3-11 
we utilized a Dean-Stark apparatus to shift the equilibrium to form the esterified 
products by extracting water from the reaction. This improved the esterification 
yield from the previously used procedure in the synthesis of the t-butyl ester 3-7. 
Cross metathesis with diol 3-2 afforded substrate 3-12 for gold cyclization. 
Unfortunately, this substrate also performed poorly in the cyclization to form 
lactone 3-8, again forming less than 10% products after 24 hours for both gold 





Scheme 3-3. Synthesis and gold catalyzed cyclization of 3-16.Error! Bookmark 
ot defined. 
 
Scheme 3-4. Synthesis and gold catalyzed cyclization of 3-20. 
 
Undeterred, we sought to optimize the allylic oxygen leaving group 
hypothesizing that the reaction efficiency would improve with an electron 
withdrawing leaving group. In order to optimize the allylic oxygen leaving group we 
choose an acetate group which could be easily and selectively installed on a 
primary alcohol. The facile installation of this functional group on substrates 3-10, 
  
34 
3-16, and 3-20 afforded the intended products in high yield and purity (Scheme 3-
5). 
 
Scheme 3-5. Synthesis of substrates 3-21, 3-22, and 3-24.Error! Bookmark not 
efined. 
 
To our delight when these substrates were subjected to a Au(III) catalyst 
substrates 3-22 and 3-23 afforded the lactone product in good yield in 48 hours at 
room temperature (Scheme 3-6). Au(I) was not reactive in this transformation 
supporting our hypothesis regarding the increased Lewis acidity of Au(III) in 
combination with the substrate optimization was essential for promoting the 
reactivity. Based on this result we sought to further investigate Au(III) as an active 





Scheme 3-6. Gold-catalyzed cyclizations of substrates 3-21, 3-22, and 3-23. 
 
Aryl allyl ethers have previously been reported by our group to promote the 
gold-catalyzed lactonization with carboxylic acids.12 Therefore, phenol based 
compounds offered an interesting opportunity to tune the reactivity of our allylic 
ether leaving group by utilizing the electronic effect of substituents on the aromatic 
ring. These phenolic structures may be installed by an efficient and simple method 
known as the Mitsunobu etherification.12 Furthermore, investigation of these 
sterically bulky leaving groups could provide useful insight for the investigation into 
diastereoselective and enantioselective synthesis of saturated oxygen 
heterocycles. 
There were two important considerations in the design of these substituted 
phenol based leaving groups. Substituents that perturbed the electronics through 
resonance would have the greatest effect on the allylic ether oxygen, therefore 
electron withdrawing substituents were installed in the ortho and para positions. 
As previously reported aryl allyl ethers are reactive at the ortho position in Claisen 
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rearrangement reactions. 12, 67 Therefore, these aryl leaving groups must always 
be substituted at the ortho positions to prevent this side reaction. We envisioned 
leaving groups to test as seen in 3-24, and 3-25 (Figure 3-1). 
 
Figure 3-1. Selected phenol leaving groups for allyl etherification. 
 
These leaving groups were installed on the most effective ester substrate 
3-20 with the benzyl ester in good yields by Mitsunobu etherification using 
diisopropyl azodicarboxylate (DIAD) and triphenylphospine (Scheme 3-7),  and 
then tested in Au(III)-catalyzed cyclization (Scheme 3-8).  
 
Scheme 3-7. Mitsunobu etherification to synthesize substrates 3-26, and 3-27. 
 
As predicted, the reactivity in Au(III)-catalyzed cyclization increased as the 
electron withdrawing nature of the allylic ether leaving group increased, with the 
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best yield of the substrate with the 3-26 leaving group. This leaving group 
introduces the facility to install an electron withdrawing allylic ether leaving group 
for less reactive -systems in gold catalysis. Additionally it was hypothesized that 
the steric bulk of this leaving group could be used in the stereoselective 
cyclizations to from cyclic ethers. 
 
Scheme 3-8.  Gold(III)-catalyzed lactonization of allyl aryl ethers.  
 
Reactions conducted 0.25M in CDCl3 utilizing 10 mol% AuCl3 / 3 AgOTf as a 
catalyst with basic alumina added as desiccant. Yield determined by NMR.Error! 




4. Synthesis of Saturated Oxygen Hetereocycles 
4.1. Diastereoselective Synthesis of Saturated Oxygen Heterocycles 
4.1.1. Gold-Catalyzed Cyclizations of Mono-Allylic Diols 
In 2008, Aponick and co-workers reported the Au(I)-catalyzed cyclizations 
of mono-allylic diols to form the 6-membered oxygen heterocycles known as 
tetrahydropyrans. Several sources of cationic gold were investigated as shown in 
Scheme 4-1.74 AuCl3 and Ph3PAuCl / AgOTf worked the best in this 
transformation giving tetrahydropyran 4-2 in excellent yields and short reaction 
times. This group chose not to investigate the Au(III) catalyst due to the 
assumption that oxophilicity of this species could hinder this catalyst in the 
presence of functional groups. They were also able to show that the 
homogenous Au(I) species is the active catalyst as Ph3PAuCl, AgOTf and triflic 
acid were poor Lewis acids for the transformation. An initial mechanistic 
investigation demonstrated that the reaction likely undergoes a SN2’ mechanism 
rather than an allyl cation intermediate as demonstrated by the complete 
conversion of mono-allylic diol 4-3 to tetrahydropyran 4-4 in just 15 minutes, 
whereas substrate 4-5 failed to react in extended reaction times and higher 
temperatures.  
According to the authors, AuCl3 did not proceed through the allyl cation 
mechanism in this experiment either. To confirm this result was also true for 
homogenous Au(III), a simple experiment was devised with allylic alcohol 4-6 in 
which 5 mol % of Au(OTf)3 formed in situ was monitored by 1H NMR analysis at 
room temperature for 24 hours then in refluxed CDCl3 for 24 h (Equation 4-1). 
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Dihydrofuran product 4-7 was not observed, supporting the hypothesis that 
Au(III) does not promote through an allyl cation intermediate. 
 




4.1.2. Gold(I)-Catalyzed Diastereoselective Synthesis of 2,6-disubstituted 
THPs and 2,5-disubstituted THF 
Aponick and co-workers investigated the diastereoselective synthesis of 




(Scheme 4-2).74 Compounds 4-10 to 4-14 were successfully synthesized in high 
yield with moderate to high diastereomeric ratios by reducing the reaction 
temperature to -50°C or -78°C. 
 
Scheme 4-2. Diastereoselective synthesis of 2,6-disubstituted THPs and THF. 
  
 
We hypothesized that the allylic ether leaving group 3-26 introduced in 
chapter 3 would improve the diastereoselectivity in the Au(III)-catalyzed cyclization 
of cyclic ethers across a broad scope of substrates at room temperature. 
This is because the electron withdrawing, sterically bulky leaving group 
would activate the reaction by promoting electron delocalization in the presence of 
Au(III) as previously reported, while the steric bulk would create a large energy 
difference between the transition state of the cis-equatorial diastereomer and 
trans-diastereomer. This is due to the concerted SN2’ mechanism which means 
the sterically bulky allylic oxygen leaving group is still present in the transition state. 
In the tetrahydropyran transition state the substituents may occupy the axial or 
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equatorial position. If both substituents occupy the equatorial position they avoid 
the steric bulk of the 1,3-diaxial interactions in the ring, and the 6-membered cyclic 
ether will assume a relatively low energy chair-conformation 4-16. However, if a 
substituent occupies the axial position it encounters the 1,3 diaxial intereactions of 
the tetrahydropyran ring, and assembles into the higher energy twist-boat 
conformation 4-17. The difference in energy between a substituent occupying the 
equatorial position over the axial position is referred to as the A-value.75 The 
relative energy difference between the transition states governs the 
diastereoselectivity of the reaction, therefore using substituents with relatively 
large A-values in combination with sterically bulky allylic oxygen leaving groups 
should create a greater energy difference between the transition states to 
preferentially form the cis-diastereomer.76 
 
Scheme 4-3. Representation of transition states in the substrate dictated 





4.2. Synthesis of Substrates for Gold(III)-Catalyzed Cycloetherfication 
Substrates for Au(III)-catalyzed cyclization to form saturated oxygen 
heterocycles were prepared by nucleophilic addition to aldehydes with various 
Grignard reagents, followed by olefin cross-metathesis, and Mitsunobu 
etherification (Scheme 4-4). 
 







Table 4-1. Isolated yields from preparation of functionalized mono-allylic diols.  
 
aYields reported in reference Error! Bookmark not defined.  bProduct lost due to 
quipment malfunction. cReaction formed a complex mixture, no product was 
isolated. 
 
The olefin-metathesis step to form 4-21a-j sometimes gave poor yields and 
low product purity due to the previously reported undesirable olefin isomerization.73 
Additionally, in order to obtain higher yields it was necessary to use greater than 6 
equivalents of the diol 3-2 because both alkenes of the reaction are considered 
type I, fast homodimerization species in the presence of Grubbs 2nd generation 
catalyst.77 In order to obtain high yields with two fast homodimerization species, 
one of the species must be used in excess in order to achieve the statistical 
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outcome of equilibrium. Additionally, the intended products were often difficult to 
separate from the excess reagent.  
Instead, we sought to improve upon reaction by using a protected allylic 
alcohol which would be a type II, slow homodimerization species.77 This would only 
require two equivalents of the reagent for good yields, and prevent the 
isomerization of the allylic alcohol to the aldehyde. We used cis-1,4-diacetoxy,-2-
butene (4-23), which allowed access to the protected diol, and an additional 
substrate 4-24 for gold-catalyzed cyclization with a leaving group previously shown 
to be sufficiently electron withdrawing to activate the allylic oxygen moiety. 
Furthermore, this acetate protecting group was easily removed in an hour in near 
quantitative yield to afford 4-21a (Scheme 4-5).  
 




In order for the Mitsunobu etherification step to be chemoselective for the 
primary alcohol, the reaction was cooled to -20 ˚C. The secondary alcohol is more 
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sterically hindered and therefore requires a higher activation energy than the 
primary alcohol. Chemoselectivity was generally good in this reaction with 
sufficient yields of the intended product, and was considered more efficient than 
using of a protecting group on the secondary alcohol. 
A symmetrical substrate was also synthesized with intention to not only 
investigate diastereoselectivity, but the utility for Au(III) to be used in 
enantioselective reactions. To prepare this substrate a nucleophilic addition was 
performed on ethyl formate with a Grignard reagent prepared from 5-
bromopentene. This intermediate was reacted in olefin metathesis with 4-23 to 
afford substrate 4-28 (Scheme 4-6). The acetate was removed to afford 4-29, and 
3-26 was installed by Mitsunobu etherification to yield 4-28. 
 




4.3. Substrate Scope of the Diastereoselective Formation of Cyclic Ethers  
A broad range of substrates were synthesized using the described methods 
to investigate the reaction scope of the Au(III)-catalyzed formation of cyclic ethers 
(Table 4-2). The experimental set-up for these reactions was designed with the 
intent to remove as much experimental variability as possible from analysis of the 
scope of this diastereoselective transformation. The reactions were performed 
under argon, at room temperature, in a dry culture tube with basic alumina as a 
desiccant. Basic alumina was used not only to adsorb any water that could 
potentially hinder the reaction, but also to neutralize any acidic protons which could 
deprotect the allylic ether leaving group, thereby decreasing diastereoselectivity. 
CDCl3 was used as a solvent so the reaction could be monitored by 1H NMR.  
To our excitement, these reactions progressed to full conversion within 24 
hours with 10 mol % of the Au(III) catalyst system. In support of our hypothesis the 
optimized allylic ether leaving group 3-25 increased the diastereoselectivity in this 
reaction at room temperature for all substrates, and in the case of forming 
tetrahydropyran rings we are not able to observe the minor diastereomer in 
determination of the diastereomeric ratio by 1H NMR analysis in entries 3-6 and 10 
of Table 4-2. Therefore, we assigned a diastereomeric ratio of 99:1 based on the 
sensitivity of the NMR. In comparison, substrates which used an allylic alcohol 
leaving group in the formation of tetrahydropyrans (entries 2, 3 and 12 of Table 4-










Reactions conducted at room temperature for 24 hours, 0.25M in CDCl3 utilizing 
10 mol% AuCl3 / 3 AgOTf as a catalyst with basic alumina added as desiccant. 
aIsolated yield. bDiastereomeric ratio determined by NMR. cRelative conversion 
determined by NMR. dIsolated yields reported in reference Error! Bookmark not 
efined.. 
 
In order to assign the configuration of the major diastereomers in the 
cyclization experiments, 1H NMR nuclear Overhauser effect spectroscopy 
(NOESY) was performed. This type of spectroscopy established correlations 
between nuclei which are physically close in proximity to each other in the 
molecule regardless of the bonds between them.78 This spectroscopic 
experiment takes advantage of the nuclear Overhauser effect (NOE) by which 
nearby atoms (within approximately 5 Å) proceed through a cross-relaxation 
mechanism related to spin-lattice relaxation. The NOESY experiment was 
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performed in a one-dimensional fashion by pre-selecting the individual 
resonances of the protons located at the 2 and 6 positions on the 
tetrahydropyran ring. Irradiation of the frequency of one resonance results in a 
strong negative signal, while neighboring nuclei are identified by weaker positive 
signal as a result of the NOE.  In all of the experiments the major diastereomer of 




Figure 4-1. 1H NMR Nuclear Overhauser effect spectra (NOESY) in the 
determination of the major and minor diastereomer of 4-28. 
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It is important to note that the diastereomeric ratio of the 5 and 7 
membered heterocycles which utilized the optimized allylic ether leaving group 
were decreased in comparison to the tetrahydropyran substrates. This is largely 
due to the energy difference of the conformations of these cyclic structures. 
Tetrahydropyran molecules are very similar to cyclohexane adopting a stable 
chair conformation with bond angles as close to 109.5˚ as possible, and 
positioning sterically bulky substituents in the equatorial positions. The relative 
energy difference between the most stable conformations “chair” and “twist-boat” 
is 5.5 kcal/mol (Figure 4-1). However, in tetrahydrofuran the 5-membered ring 
has some torsional and ring strain. The energy difference between the axial and 
equatorial positions of the envelope conformation is significantly diminished and 
the ring rapidly interconverts between the two. In an oxepane the relative energy 
difference is also lower than in tetrahydropyran, and the ring may adopt many 
different lower energy conformations the analysis of which is actually quite 
complex. The “twist-chair” is the lowest energy conformation, while the “boat” 
forms are only few kilocalories per mole higher in energy.79 
Therefore, the allylic ether leaving group we have introduced aids in the 
diastereoselective formation of these cyclic ethers. However, in order to improve 
the diastereomeric ratios observed in the tetrahydrofuran and oxepane reactions 
we would have to decrease the temperature of our reaction to shift the Boltzman 




Figure 4-2. Relative energy minima of the conformations of tetrahydropyran. 
In the oxepane example we observed a 20 % isolated yield of the intended 
product, however in this example we obtain only 46 % conversion of the starting 
material by 1H NMR analysis at 24 hours. We isolated a secondary product and 
determined the structure to be alkenone 4-50. We hypothesized alkenone 
formation occurred after the formation of the oxepane product by the original 
proposed SN2’ mechanism. The Au(III) likely coordinates to the allylic ether 
present in the product, which acts to delocalize the -electrons to promote an 
elimination to form an enol ether. Protodeauration of the complex followed by 





Scheme 4-7.  Proposed mechanism for the formation of alkenone product 4-37. 
 
 
Analysis of the scope of the Au(III)-catalyzed reaction to form saturated 
oxygen heterocycles indicated this methodology is efficient for a broad range of 
substrates. As predicted the optimized allylic ether leaving group dramatically 
improved the diastereoselectivity of this reaction at room temperature for all 
substrates, however tetrahydropyrans and oxepanes had a lower diastereomeric 
ratio. Good isolated yields were reported though the catalyst loading was high. In 
order to determine the efficiency of this reaction an investigation was performed 
to optimize the conditions and analyze the reaction rate. 
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4.4. Optimization of Conditions and Control Experiments 
To determine the optimal catalyst loading, and to confirm if homogenous 
Au(III) was the active catalyst a study was performed with mono-allylic diol 
substrate 4-21a to form tetrahydropyran 4-33 (Equation 4-2, Table 4-2). 
Quantitative GC yields were obtained in less than 10 minutes using only 1 mol % 
of AuCl3 / 3 AgOTf (entry 2, Table 4-2). In comparison 1 mol % of 
PPh3AuCl/AgOTf required 40 minutes to achieve a 94 % GC yield (entry 4, Table 
4-2). This table also shows cationic gold(III) complex was the active species 
because no or very minimal conversion was observed using AuCl3 and AgOTf 
separately. Additionally, transformation was not reactive with AgCl, basic alumina 
or MS 4 Å. 
To test the robustness of the developed catalyst system a variety of 
solvents were tested in open air using substrate 4-24 to form tetrahydropyran 4-
33 (Equation 4-3, Table 4-3). The majority of solvents tested gave quantitative 
yield of the product in less than 10 minutes with just 1 mol % of AuCl3 / 3 AgOTf. 
Polar coordinating solvents like acetone, methanol and water (entries 7-9) were 
not suitable solvents for the reaction. This is likely because the solvent strongly 
















Table 4-4. Solvent considerations. 




5. Gold(III)-Catalzed Cyclization to Form Spiroketals  
5.1. Spiroketals in Nature  
Spiroketals are a unique structural feature in which cyclic ethers are 
connected by single carbon called the spiro carbon. Each of the ketal oxygens 
joined by the spiro-carbon belongs to one of the rings. The spiroketal ring system 
is an important structural feature observed in a myriad of natural products with 
promising and diverse biological activity such as insect pheromones, polyether 
ionophores, macrolide antibiotics, and steroidal saponins.80 Some examples of this 
natural product which possess this spiroketal structural motif are tautomycin 5-1,81 
okadaic acid 5-2, 82  and spongistatin 5-3 83  which are all protein phosphatase 
inhibitors (Figure 5-1). 
These rigid, structurally complex features often serve as pharmacophores 
in biological systems due to the conformational constraint of these moieties making 
them attractive targets in reaction methodology.84 The synthesis of spiroketals still 
remains a significant challenge in synthesis and few examples of metal catalyzed 





Figure 5-1. Spiroketal-containing natural products.  
 
5.2. Conformational Aspects of Spiroketal Structures 
The stereochemistry of spiroketals is thermodynamically influenced by the 
anomeric effect.85 However, intramolecular hydrogen bonding, steric interactions 
and chelation may also contribute to the conformation of these spirocyclic 
systems. 86  The anomeric effect is described as the propensity of an 
electronegative atom like oxygen at the anomeric carbon of a pyranose ring to 
occupy the axial position of the ring. This orientation allows the lone pair of the 
oxygen to interact with the * antibonding orbital of the C-O bond (Figure 5-2). If 
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the substituent is in the equatorial position of the ring this orbital interaction is not 
possible making this a conformation much higher in energy. Each anomeric 
interaction increases the stability by decreasing the total energy of the molecule 
by approximately 1.4 – 2.4 kcal/mol.87  
 
Figure 5-2. Possible positions of an electronegative hydroxyl substituent at the 
tetrahydropyran anomeric carbon. 
The 6,6-spiroketal core may exist in four different conformations which can 
be interconverted by ring flipping (Figure 5-3).88 The most thermodynamically 
stable conformation (A) has two anomeric interactions. Two possible 
conformations exhibit one anomeric effect (B and C). The most thermodynamically 
unfavorable isomer is the conformation with no anomeric effect (D). 
The traditional method to synthesize spiroketals is the acid-catalyzed 
cyclization of a dihydroxyketone (Equation 5-1).89  This method is effective at 
synthesizing the thermodynamically favorable spiroketals stereoisomers which 
benefit from conformational anomeric effects.85 Since most synthetic targets have 




Figure 5-3. Possible conformations of a spiroketal.  
However, substrates with acid-labile functional groups limits the reaction 
scope. Additionally, synthesis of nonanomeric or thermodynamically unfavorable 
spiroketals are very challenging using this method. 
 
 
5.3. Metal-Catalyzed Spiroketalization 
Cationic metal complexes have been found to be effective for the Lewis 
acid-catalyzed cyclization to form spiroketals. Floreancig and co-workers 
described the application of the thermodynamic stereocontrolled process to 
synthesize spiroketals by transposition/oxa-Micahel addition. They reported high 
stereocontrol in the synthesis of spiroketals from allylic alcohols using rhenium 




diastereoselective formation of spiroketals from allylic acohols in good yield.91 This 
cyclization was proposed to proceed through a carbocation intermediate which 
allowed for the thermodynamically favorable diastereomer but excluded this 
reaction from stereo-retention towards enantioselective products. Aponick and co-
workers have reported on the Au(I)-catalyzed spiroketalization of protected 
monoallylic propargyl alcohols.39 This approach to synthesize unsaturated 
spiroketal structures addressed the regioselectivity issues commonly reported in 
metal-catalyzed spiroketalization of alkynes. 
 
Scheme 5-1. Selected examples of metal-catalyzed spiroketalizations. 
 
The selected examples are powerful synthetic methods to yield spiroketals, 
but these synthetic methodologies are limited to the formation of the specific 
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substrates, and there are very few reports of the formation of reaction cascade to 
form bis-spiroketals.  
 
5.4. Gold(III)-Catalyzed Spiroketalization of Monoallylic Ketodiols 
The recent work of a graduate student from Aponick’s group sought to 
synthesize spiroketals from monoallylic ketodiols using cationic metals. Palmes 
discovered Pd(II) was the best catalyst in this reaction (Scheme 5-2), however 
homogenous Au(III) was not tested in this reaction.92 Au(I) was ruled out early in 
the investigation as being less efficient though it successfully catalyzed the 
reaction although in poor yield. Based on the results presented in this thesis we 
hypothesized homogenous Au(III) complexes may be able to activate the carbonyl 
and allylic alcohol moiety towards the formation of spiroketals, and the more 
synthetically difficult bis-spiroketals utilizing a similar reaction cascade. 
 





To test our hypothesis, an unsubstituted monoallylic ketodiol was 
synthesized from commercially available -valerolactone by formation of the 
corresponding Weinreb amide 5-15 and protection of the primary alcohol to afford 
the t-butyldimethylsilyl ether 5-16 (Scheme 5-3). Nucleophilic addition of a 
Grignard reagent prepared from 5-bromopentne to the substrate yielded 5-17. 
Which was then used in olefin cross-metathesis with Z-2-butene-1,4-diol to afford 
the mono-allylic ketodiol 5-18. The optimized allylic ether leaving group 2,6-
dimethyl-4-nitrophenol was installed using Mitsunobu etherification, and the 
protecting group was removed to obtain the desired substrate 5-20. 
 




Substrate 5-20 was then treated with 2 mol % of the catalyst AuCl3 / 3 AgOTf 
in CDCl3 with basic alumina added as a dessicant. TLC showed complete 
consumption of the starting material after just 5 minutes. However, due to the 
polarity of the compounds detected it was believed that this was the hemiketal that 
had been formed by the Lewis acid activation of the carbonyl, and the reaction was 
allowed to react overnight in order to form the spiroketal. The reaction was checked 
by 1H NMR after 15 hours to show only the hemiketal had formed (Scheme 5-4). 
After heating the reaction at reflux for an additional 24 hours no spiroketal was 
formed. The hemiketal was isolated in 62% yield with good diastereoselectivity, 
however this yield is the result of the equilibrium formed between the hemiketal 
and the starting material in the presence of a Lewis acid.  
 
Scheme 5-4. Au(III)-catalyzed spiroketallization of 5-20. 
 
We believed it was unlikely the oxophilicity of Au(III) was preventing the 
reaction from progressing, and hypothesized that the sterically bulky allylic ether 
leaving group was preventing nucleophilic attack with the sterically bulky 
thermodynamically favored, axial, anomeric alcohol. Therefore, a smaller allylic 
ether leaving group could decrease the steric bulk and allow the reaction to 
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progress to completion. Substrate 5-22 was synthesized by olefin metathesis of 5-
17 with Z-1,4-diacetoxy-2-butene and deprotection of the TBS ether. The acetoxy 
leaving group could enhance the reactivity of the allylic oxygen, while decreasing 
the steric bulk of this functional group. 
 





6.1. Introduction and Background of Centrolobine 
The Au(III) catalyst methodology developed in this thesis was utilized 
toward the total synthesis of centrolobine. In 1959, a group of scientists discovered 
extracts from the heartwood of Centrolobium robustum exhibited bacteriostatic 
activity. It was not until 1964 that one of the active ingredients was extracted, 
isolated, and characterized as 2[β(p-hydroxyphenyl)ethyl-2-(p-
methoxyphenyl)tetrahydropyran, referred to as (+)-centrolobine ((+)-6-1, Figure 6-
1).93  
 
Figure 6-1. (+)-Centrolobine. 
Centrolobine has since been found in numerous plants in the Brazilian 
Amazon and the compound has acute antibiotic and antifungal activity, therefore 
making it a promising drug candidate or lead for antibiotics.93, 94 , 95  Both 
enantiomers, (+)- and (–)-centrolobine, are active antibiotic agents and have been 
isolated from many different trees, primarily Centrolobium robustum and 
Centrolobium tomentosum. 93,94,95 Additionally, (–)-centrolobine has recently been 
isolated from the stems of a completely different genus, Brosimum potabile.96 
The scientific community has developed an interest in the synthesis of this 
compound, and several total syntheses have been achieved.97 In the multiple 
synthetic pathways devised there have been many different methods by which the 
  
66 
central tetrahydropyran ring of centrolobine has been formed.97, 98 , 99   We 
hypothesized that we would be able to incorporate our diastereoselective Au(III)-
catalyzed etherification in a new stereoselective route towards centrolobine.  
The absolute configuration of centrolobine was first determined in 2002 by 
the first enantioselective total synthesis of (–)-centrolobine (Scheme 6-1).98 The 
optically pure keto sulfoxide (R)-6-4 was prepared by condensation of glutaric 
anhydride (6-2) and (R)-6-3. This intermediate was then esterified with 
dimethylsulfate and potassium carbonate to obtain (R)-6-5. The 1,3 diketone was 
then stereoselectively reduced with DIBAL-H and ZnBr2 to obtain 6-6 in high 
diastereomeric excess. From the proposed mechanism,100 and the characteristic 
1H NMR spectrum for each diastereomer,101 the absolute configuration of the 
hydroxylic carbon on 6-6 was assigned as R stereoisomer. In order to form the 
tetrahydropyran ring, this group followed the work of Olah102 and Nicolaou.103 By 
treating the hydroxyl ketone with excess Et3SiH and TMSOTf they were able to 
prepare the respective unsymmetrical cyclic ether by reductive condensation of 
carbonyl compounds. The stereospecificity of the etherification was directed by the 
R hydroxyl group of 6-7, and the syn stereochemistry was assigned by 1H NMR 
Nucear Overhauser enhancement experiments. This stereochemistry was 
conserved through the rest of the 9 step synthesis to obtain (–)-centrolobine in 






Scheme 6-1. First enantioselective total synthesis of (–)-centrolobine. 
 
 
6.2. Total Synthesis of (±)-Centrolobine 
Heidi Dimmitt, a prior Vyvyan group member, had developed a concise 
synthesis of centrolobine involving Au(I)-catalyzed tetrahydropyran formation 
(Scheme 6-2).12 The synthetic approach began with a nucleophilic addition of a 
Grignard reagent prepared from 5-bromo-1-pentene with p-anisaldehyde to form 
6-12. Olefin-metathesis of the terminal alkene (Z)-2-butene-1,4-diol using Grubbs’ 
2nd generation catalyst formed 6-13. The primary alcohol was reacted in a 
Mitsunobu etherification with 6-14 to from allyl aryl ether 6-15. Au(I) catalyzed 
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cyclization of this intermediate yield the central tetrahydropyran of centrolobine as 
a single diastereomer due to the sterically bulky leaving group 6-14. The terminal 
alkene was coupled to the THP protected 4-iodophenol using an alkyl Suzuki 
coupling to yield 6-17. Deprotection of the THP-protecting group completed the 6-
step synthesis of (±)-centrolobine with an overall yield of 2%. 
 





Due to the low overall yield in the total synthesis of (±)-centrolobine we 
believed we could improve the synthetic pathway by utilizing fewer steps that 
promoted higher yields of reaction intermediates. First, we designed the synthesis 
around a the Au(III)-catalyzed cyclization step. In this design we hypothesized the 
sterically bulky allylic aryl group in centrolobine would enhance the 
diastereoselectivity of the reaction without installation of a sterically bulky leaving 
group. Second we hypothesize coupling the east and west fragments of 
centrolobine could be easily accomplished by an olefin metathesis reaction as the 
terminal alkene of the west fragment would be a type I fast homodimerization 
species, while the east fragment would be a type II slow homodimerization species. 
Lastly, these fragments could be assembled in high yield using a simple 
nucleophilic addition with the corresponding Grignard reagent (Scheme 6-3). 
Furthermore, we hypothesized that we may be able to obtain an enantiopure 
centrolobine by utilizing an enantioselective Corey-Bakshi-Shibata reduction to 





Scheme 6-3. Retrosynthetic analysis of centrolobine towards a more efficient total 




The synthesis began with the nucleophilic addition of prepared Grignard 
reagent. The western fragment was synthesized by a method similar to the 
pathway devised by Dimmit; by addition of 6-11 to p-anisaldehyde 6-10, however 
with an improved yield (85%, Scheme 6-4). The eastern fragment was synthesized 




Scheme 6-4. Nucleophilic addition with Grignard reagents in the preparation of 
intermediates 6-12 and 6-18. 
 
 
Unfortunately, when these substrates were subjected to olefin metathesis 
with Grubbs 2nd generation catalyst 6-18 proceeded through a rapid 
homodimerization/isomerization pathway to form the oxidized and conjugated 
species 6-19 (Equation 6-1). This side reaction occurred even in the presence of 
additives like p-benzoquinone and acetic acid, which have been reported to 
suppress undesirable olefin isomerization.73 The formation of this species was 
likely also driven by Le Châtelier's principle as the compound exhibited poor 
solubility in DCM and chloroform, and readily precipitated out of solution. 
 
In order to prevent this undesirable product and make the reaction more 
robust and efficient, a protecting group was installed. In the course of this thesis 




olefin isomerization and may be used in stoichiometric equivalents for high yields. 
Therefore, we installed an acetoxy protecting group on to 6-18 by reaction of acetic 
anhydride and dimethylaminopyridine to synthesize 6-19 (Scheme 6-5). 
When 6-12 and 6-19 were subjected to olefin metathesis conditions the 
reaction proceeded to the product 6-20 without the formation of any observable 
side products. Though the yield for this reaction was low, unreacted starting 
materials were recovered indicating the reaction had not gone to complete 
conversion. This can easily be improved by using a higher catalyst loading, a 
higher temperature and a longer reaction time. 
The substrate 6-20 was then cyclized in one minute with just 1 mol % AuCl3 
/ 3 AgOTf as a single diastereomer 6-21. Hydrogenation to reduce the olefin and 
remove the benzyl ether protecting group in single step was attempted on 6-21 
using palladium on carbon and hydrogen gas. After 24 hours a nearly complete 
conversion of the starting material was observed by TLC, however a mixture of 





Scheme 6-5. Synthetic pathway to form (±)-centrolobine. 
 
Future work will attempt to improve the synthetic pathway of this reaction 
towards the total synthesis of (±)-centrolobine. First, the acetate protection may be 
performed with the in situ generated oxygen anion from the nucleophilic addition 
reaction. This would reduce the number of total steps and should increase the total 
yield across the two reactions. Though the yield of the olefin metathesis reaction 
was only 12 % there was good recovery of the starting materials (81 % recovered 
6-19, and 41% recovered 6-12). Therefore, adjusting the reaction conditions to 
allow for increased catalyst loading, increased reaction temperature and longer 
reaction time should improve the observed yield in this reaction. The Au(III)-
catalyzed cycloetherification to form 6-21 had a low isolated yield though complete 
conversion was observed by TLC after 1 minute. This is due to the complex mixture 
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of minor products that formed in the approximately 15 minutes during the analysis 
of the reaction mixture by TLC. These undesirable side reactions may be 
prevented by reducing the reaction temperature, however a more detailed analysis 
of these minor products is required to determine the mechanism of side product 
formation. Lastly, though the hydrogenation was ineffective in this case the 
hypothesis is that excess hydrogenation may have cause undesirable side 
reactions to occur. Therefore, performing the hydrogenation under more mild 




7. Conclusions and Future Work 
 The work presented in this thesis has demonstrated the synthesis of -
butyrolactones and saturated oxygen heterocycles utilizing homogenous Au(III) 
complexes. We were able to synthesize the substrates by utilizing readily available 
starting materials, and efficient synthetic pathways. In the synthesis of -
butyrolactones we observed electron donating, cation accepting ester substituents 
enhanced the reactivity in Au(III) catalysis. We were able to demonstrate the use 
of an electron withdrawing, sterically bulky allylic ether leaving groups allowed for 
increased reactivity in Au(III) catalyzed cyclizations to form -butyrolactones. The 
steric bulk of these allylic ether leaving groups allowed for stabilization of the 
transition state to increase diastereoselectivity in the synthesis of saturated oxygen 
heterocycles. This reaction performed smoothly in the presence of many different 
functional groups. We then sought to use the optimized conditions in more difficult 
saturated oxygen heterocycles structural moieties observed in complex synthetic 
targets. 
In the attempt to synthesize spiroketal structural features we observed that 
Au(III) was an exceptional Lewis acid for activation of the ketone for nucleophilic 
addition, however the electron withdrawing allylic ether leaving group may have 
prevented the final spiroketalization due to steric bulk. The reactivity of Au(III) 
catalyst system was effectively used to synthesize the central tetrahydropyran 
structural feature in (±)-centrolobine.  
Based on these results we have hypothesized new routes in which this 
Au(III) catalyst system may be employed. We believe the oxophilicity of Au(III) is 
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potential advantageous in the catalytic activation of certain oxygen functional 
groups like carbonyls, epoxides, and , – unsaturated carbonyls, which could 
introduce new reaction methodologies. Activation of these structural features could 





8. General Experimental Procedures 
All procedures involving air- or moisture-sensitive reagents were performed 
in oven dried glassware under an argon atmosphere. Ether, THF, CH2Cl2 and 
toluene were dried by passing through a column of activated alumina using an 
Innovative Technology Pure SolvTM 400 Solvent Purification System. In all 
procedures, unless otherwise noted, concentration was performed using rotary 
evaporation. Dessicants like MgSO4 and NaSO4 were removed using gravity 
filtration and fluted filter paper (VWR Qualitative Filter Paper 415). 
For purifications, column diameters, and solvent mixtures were given (for 
example “40 mm column, 6:1 Hex: EtOAc”). Flash chromatography was performed 
with hand packed columns of silica gel (Silicycle, Chemical Division, 230-400 
mesh). Thin Layer Chromatography was done using Sorbent Technologies 200 
m silica layer fluorescence UV254 TLC plates. 
1H and 13C NMR spectra were acquired on either Varian Mercury (300 MHz) 
or UNITYINOVA (500 MHz) spectrometers. All chemical shifts were reported in ppm, 
and all coupling constants are reported in Hertz. 1H chemical shifts were 
referenced to tetramethylsilane (TMS) at 0.00 ppm. 1H NMR data are reported in 
the following format: chemical shift [integral, multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, m = multiplet), coupling constant(s) J, proton assignment]. 
13C NMR spectra are referenced to CDCl3 at 77.1 ppm.  
Infrared spectra were obtained on a Thermo Scientific Nicolet iS10 FT-IR 
spectrometer with Smart iTR attachment. All absorptions are reported in cm-1. 
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Absorbances in the IR spectrum are referenced to as: w = weak, m = medium, s = 
strong, and br = broad. 
 High resolution mass spectrometry was performed by the Mass 
Spectrometry Facility at the University of California, Irvine. 
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Preparation of 2,6-dimethyl-4-nitrophenol 
 
Notebook Entry: RDLB037 
2,6-dimethylphenol (20.0.34 g, 164 mmol), concentrated sulfuric acid (18M, 
30 mL) were added to a 500 mL Erlenmeyer flask and stirred until the solid was 
dissolved forming a pink solution. After 5 minutes, the solution solidified to a pink 
solid. Glacial acetic acid (17.4 M, 100 mL) was added to dissolve the pink solid. 
The reaction mixture was stirred until solution was homogenous and then 
submerged in an ice bath. A mixture of nitric acid (15 mL, 16M) and sulfuric acid 
(15 mL, 18M) was added drop wise over a period of 1 hour.  Reaction vessel was 
taken out of ice bath and allowed to slowly warm to room temperature. Na2CO3 
was added slowly until pH was around 3. The reaction mix was vacuum filtered 
over filter paper and rinsed with cold water to provide 4-nitro-2,6-dimethylphenol 
(15.8941 g, green solid 58 %).  
FTIR: 3030 (sp2 C-H stretch), 2920 (sp3 C-H stretch), 1588/1517 (N-O stretch) cm-
1.  
1H NMR (CDCl3, 500 MHz): δ 7.93 (s, 2H), 2.32 (s, 6H) ppm.  




Preparation of 1-cyclohexylhex-5-en-1-ol 
 
Notebook Reference: RDLA202 
An oven dried 100 mL 2-neck round bottom flask with stir bar was charged 
with magnesium turnings (546.9 mg, 22.50 mmol) and fitted with a reflux 
condenser and placed under argon. THF (15 mL) was added via syringe followed 
by dibromoethane (4 drops) and allowed to stir for 10 mins in order to activate the 
magnesium. 5-bromo-1-pentene (1.78 mL, 15.0 mmol) was diluted in 10 mL and 
added drop wise over 15 minutes. The reaction was then heated at reflux for 1 
hour. The reaction was cooled to room temperature and 
cyclohexyanecarboxaldehyde (1.91 mL, 15.8 mmol) was added via syringe and 
the reaction was heated at reflux for 2 hours. The reaction was cooled to room 
temperature, poured over 10% HCl (50 mL), extracted with ether (3 × 30 mL), dried 
over magnesium sulfate, and concentrated in vacuo. The resultant crude oil was 
purified via flash chromatography (6:1 Hex:EtOAc, Rf = 0.18) to afford a clear, 
colorless oil (2.4761 g, 13.583 mmol, 91%). 
FTIR (ATR): 3350 (br, OH stretch), 3076 (w, vinyl CH stretch), 2922, 2852 (m, alkyl 
CH stretch), 1640, 1449 (m, vinyl C-C stretch), 1316, 1261 (w, alkyl C-C stretch), 
1086 (w, CO stretch), 991, 996, 908 (m) cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.83 (ddt, J = 17.0, 10.3, and 3.5, 2H), 5.04 (dd, J = 
17.2, 1.6 1H), 4.95 (dd, J = 8.9, 1.1,1H), 3.60 (1H, sept., J 3.6), 2.07 (4H, q, J 5.1), 
1.52-1.43 (8H, m) ppm. 
13C NMR (125 MHz, CDCl3): δ 138.9, 114.7, 75.7, 43.8, 33.3, 30.4, 29.3, 27.8, 26.6, 
26.5, 26.4, 26.2 ppm. 
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Prepartation of (E)-7-cyclohexylhept-2-ene-1,7-diol 
 
Notebook Reference: RDLA206 
An oven dried 100 mL round bottom flask with a stir bar was charged with 
p-benzoquinone (88.1 mg, 0.815 mmol) and Grubbs 2nd Generation Catalyst 
(230.6 mg, 0.2716 mmol) and placed under argon. DCM (25 mL) was added via 
syringe followed by (Z)-but-2-ene-1,4-diol (6.70 mL, 81.49 mmol) and 1-
cyclohexylhex-5-en-1-ol (2.4761 g, 13.58 mmol). The reaction was stirred at room 
temperature for 2 days. An additional 4 equivalents of (Z)-but-2-ene-1,4-diol was 
added every 24 h, and the reaction was monitored by TLC for consumption of 
starting material. The reaction mixture was concentrated in vacuo, and purified via 
flash chromatography (2:1 Hex:EtOAc, Rf = 0.41) to afford a colorless oil (1.309 g, 
7.725 mmol, 57 %). E:Z ratio determined to be 6:1 by comparison of 1H NMR 
chemical shifts at 4.07 and 4.11 ppm. 
FTIR (ATR): 3383 (br), 2924 (w), 1670 (m), 1449 (m), 969 (m) cm-1. 
1H NMR (500 MHz, CDCl3): δ  5.74-5.58 (m, 2H), 4.07 (d, J = 4.5 Hz, 2H), 3.36-
3.32 (m, 1H), 2.10-2.03 (m, 2H), 1.80-0.95 (m, 17H) ppm.  
13C NMR (125 MHz, CDCl3): δ 132.5, 129.2, 75.8, 63.2, 43.5, 33.3, 32.1, 29.1, 27.7, 




Preparation of 1-cyclohexylpent-4-en-1-ol 
 
Notebook Reference: RDLA203 
An oven dried 100 mL 2-neck round bottom flask with stir bar was charged 
with magnesium turnings (546.9 mg, 22.50 mmol) and fitted with a reflux 
condenser and placed under argon. THF (15 mL) was added via syringe followed 
by dibromoethane (4 drops) and allowed to stir for 10 mins in order to activate the 
magnesium. 4-bromo-1-butene (1.53 mL, 15.0 mmol) was diluted in 10 mL and 
added drop wise over 15 minutes. The reaction was heated at reflux for 1 hour. 
The reaction was cooled to room temperature and cyclohexyanecarboxaldehyde 
(1.91 mL, 15.8 mmol) was added via syringe and the reaction was heated at reflux 
for 2 hours. The reaction was cooled to room temperature, poured over 10% HCl 
(50 mL), extracted with ether (3 × 30 mL), dried over magnesium sulfate, and 
concentrated in vacuo. The resultant crude oil was purified via flash 
chromatography (6:1 Hex:EtOAc, Rf = 0.18) to afford a clear, colorless oil (2.107 
g,  12.52 mmol, 83%). 
FTIR (ATR): 3350 (br, OH stretch), 3076 (w, vinyl CH stretch), 2922, 2852 (m, alkyl 
CH stretch), 1640, 1449 (m, vinyl C-C stretch), 1316, 1261 (w, alkyl C-C stretch), 
1086 (w, CO stretch), 991 (m), 996 (m), 908 (m) cm-1. 
1H NMR (500 MHz, CDCl3): δ  5.83 (ddt, J = 17.0, 10.3, 3.5, 1H), 5.04 (dd, J = 17.2, 
1.6, 1H), 4.95 (dd, J = 8.9, 1.1, 1H), 3.60 (septet, J = 3.6, 1H), 2.07 (q, J = 5.1, 4H), 
1.52-1.43 (m, 8H) ppm. 
13C NMR (125 MHz, CDCl3): δ 138.9, 114.7, 75.7, 43.8, 33.3, 30.4, 29.3, 27.8, 26.6, 
26.5, 26.4, 26.2 ppm ppm. 
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Preparation of (E)-6-cyclohexylhex-2-ene-1,6-diol 
 
Notebook Reference: RDLA207 
An oven dried 50 mL round bottom flask with a stir bar was charged with p-
benzoquinone (74.4 mg, 0.688 mmol) and Grubbs 2nd Generation Catalyst (194.7 
mg, 0.2293 mmol) and placed under argon. DCM (25 mL) was added via syringe 
followed by (Z)-but-2-ene-1,4-diol (5.66 mL, 68.8 mmol) and 1-cyclohexylpent-4-
en-1-ol (1.9298 g, 11.47 mmol). The reaction was stirred at room temperature for 
2 days. An additional 4 equivalents of (Z)-but-2-ene-1,4-diol was added every 24 
h, and the reaction was monitored by TLC for consumption of starting material. 
The reaction mixture was concentrated in vacuo, and purified via flash 
chromatography (1:1 Hex:EtOAc, Rf =0.41 ) to afford a colorless oil (368.6 mg, 
1.859  mmol, 16%). E:Z ratio determined to be 6:1 by comparison of 1H NMR 
chemical shifts at 4.07 and 4.11 ppm. 
FTIR (ATR): 3330(br, OH stretch), 2922 (s, vinyl CH stretch), 2851 (s, alkyl CH 
stretch), 1448 (m, vinyl C-C stretch), 1087, 1000 (s, CO stretch), 968 (s, vinyl CH 
oop bend) cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.65 (m, 2H), 4.07 (d, J = 4.5 Hz, 2H, OCH), 3.34 
(m, 1H), 2.06 (m, 2H), 1.75-0.94 (m, 13H) ppm. 
13C NMR (125 MHz, CDCl3): δ 133.0, 129.3, 76.1, 63.7, 43.6, 33.6, 29.3, 27.7, 26.5, 







Notebook Reference: RDLA215 
An oven dried 50 mL flask with a stir bar was charged with 
triphenylphosphine (550.8 mg, 2.100 mmol) and 2,6-dimethyl-4-nitrophenol (367.8 
mg, 2.200 mmol), and placed under argon. Dry THF (10 mL) was added to the 
flask via syringe followed by (E)-7-cyclohexylhept-2-ene-1,7-diol (368.6 1.859 
mmol). The reaction flask was cooled to -78° C (dry ice/acetone bath). DIAD (0.41 
mL, 2.1 mmol) was diluted with dry THF (10 mL) and added dropwise over 15 
minutes. The reaction was stirred for 48 h. The reaction mixture was diluted with 
ether, washed with 10% NaOH solution (3 × 30 mL) and dried over anhydrous 
magnesium sulfate. The mixture was gravity filtered, concentrated in vacuo. The 
crude product was purified via column chromatography (2:1 Hex:EtOAc) to give 
(E)-1-(hex-2-en-1-yloxy)-2,4-dimethylbenzene (102 mg, 0.294 mmol,16 %). 
FTIR (ATR): 3402 (br), 2948 (m), 2934 (m) 2867 (m), 1588, 1508, 1472 (m), 1344, 
1211 (s), 1100, 1078 (s) 963, 902 (s) cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.95 (s, 2H), 5.71 (ddddd, J = 13.4, 7.9, 6.7, 1.3, 1.3, 
1H), 5.58 (ddddd, J = 12.6, 8.4, 5.9, 1.5, 1.5,1H), 5.19 (dd, J = 4.6, 2.0, 2H),  4.14 
(ddd, J = 11.8, 5.7, 1.0, 1H), 3.92 (m, 2H), 2.33 (s, 6H), 2.15-0.96 (m, 12H) ppm. 
13C NMR (125 MHz, CDCl3): δ 158.0, 134.5, 126. 5, 124.5, 125.7, 103.1, 67.8 67.0, 
43.5, 33.6, 32.3, 29.3, 27.6, 26.4, 25.2, 23.6, 15.9 ppm.  
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Preparation of 2,2-dimethyloct-7-en-3-ol 
 
Notebook Reference: RDLA222 
An oven dried 100 mL 2-neck round bottom flask with stir bar was charged 
with magnesium turnings (1.0338 g, 42.534 mmol) and fitted with a reflux 
condenser and placed under argon. THF (15 mL) was added via syringe followed 
by dibromoethane (4 drops) and allowed to stir for 10 mins in order to activate the 
magnesium. 5-bromo-1-butene (2.73 mL, 23.0 mmol) was diluted in 10 mL and 
added drop wise over 15 minutes. The reaction was then heated at reflux for 1 
hour. The reaction was cooled to room temperature and pivaldehyde (2.00 mL, 
18.41  mmol) was added via syringe and the reaction was heated at reflux for 2 
hours. The reaction was poured over 10% HCl (50 mL), extracted with ether (3 × 
30 mL), dried over magnesium sulfate, and concentrated in vacuo. The resultant 
crude oil was purified via flash chromatography (6:1 Hex:EtOAc, Rf  = 0.46) to 
afford a clear, colorless oil (1.4026  g, 8.98  mmol, 50 %). 
FTIR (ATR): 3355 (br), 2953 (w), 2869 (m), 1640 (s), 1479, 1364 (s), 1076, (s), 
908 (s) cm-1. 
1H NMR (500 MHz, CDCl3): δ  5.92 – 5.78 (m, 1H), 5.06 (dq, J = 17.1, 1.7 Hz, 1H), 
4.97 (ddt, J = 10.2, 2.3, 1.2 Hz, 1H), 3.21 (dd, J = 10.6, 1.9 Hz, 1H), 2.38 – 2.27 
(m, 1H), 2.11 (ddtt, J = 14.5, 8.7, 7.2, 1.4 Hz, 1H), 1.61 (dddd, J = 13.8, 9.0, 7.1, 
1.9 Hz, 1H), 1.36 (dddd, J = 13.9, 10.6, 8.7, 5.3 Hz, 1H), 1.03 – 0.77 (m, 10H), 
0.75 (s, 1H) ppm. 





Preparation of (E)-8,8-dimethylnon-2-ene-1,7-diol 
 
Notebook Reference: RDLA230 
An oven dried 100 mL round bottom flask with a stir bar was charged with 
p-benzoquinone (53.9 mg, 0.500 mmol) and Grubbs 2nd Generation Catalyst 
(141.3 mg, 0.1665 mmol) and placed under argon. DCM (25 mL) was added via 
syringe followed by (Z)-but-2-ene-1,4-diol (2.74 mL, 33.30 mmol) and 2,2-
dimethyloct-7-en-3-ol (1.301 g, 8.324 mmol). The reaction was stirred at room 
temperature for 2 days. An additional 4 equivalents of (Z)-but-2-ene-1,4-diol was 
added every 24 h, and the reaction was monitored by TLC for consumption of 
starting material. The reaction mixture was concentrated in vacuo, and purified via 
flash chromatography (3:1 Hex:EtOAc, Rf =0.29 ) to afford a colorless oil (1.131g, 
6.071 mmol, 73%). E:Z ratio determined to be 6:1 by comparison of 1H NMR 
chemical shifts at 4.11 and 4.14 ppm. 
FTIR (ATR): 3340 (br), 2948, 2867 (m), 1460, 1393, 1363, 1316 (w), 1080, 1001 
(s), 969, 908 (s) cm-1.  
1H NMR (500 MHz, CDCl3): δ 5.77 – 5.63 (m, 1H), 4.11 (d, J = 5.3 Hz, 2H), 3.21 
(d, J = 10.3 Hz, 1H), 2.20 – 2.03 (m, 2H), 1.73 – 1.63 (m, 1H), 1.61 – 1.51 (m, 1H), 
1.44 (dddd, J = 18.6, 12.2, 9.9, 5.7 Hz, 2H), 1.34 – 1.22 (m, 1H), 0.91 (t, J = 2.0 
Hz, 9H). 





Mitsunobu Etherification: Preparation of (E)-9-(2,6-dimethyl-4-
nitrophenoxy)-2,2-dimethylnon-7-en-3-ol 
 
Notebook Reference: RDLA244 
An oven dried 50 mL flask with a stir bar was charged with 
triphenylphosphine (550.6 mg, 2.100 mmol) and 2,6-dimethyl-4-nitrophenol (367.8 
mg, 2.200 mmol), and placed under argon. Dry THF (10 mL) was added to the 
flask via syringe followed by (E)-8,8-dimethylnon-2-ene-1,7-diol (372.6 mg, 2.0 
mmol). The reaction flask was cooled to -78° C (dry ice/acetone bath). DIAD (0.41 
mL, 2.1 mmol) was diluted with dry THF (10 mL) and added dropwise over 15 
minutes. The reaction was stirred for 48 h. The reaction mixture was diluted with 
ether, washed with 10% NaOH solution (3 × 30 mL) and dried over anhydrous 
magnesium sulfate. The mixture was gravity filtered, concentrated in vacuo. The 
crude product was purified via column chromatography (1 ½ in width, 18 in long 
column, 2:1 Hex:EtOAc) to give ((E)-9-(2,6-dimethyl-4-nitrophenoxy)-2,2-
dimethylnon-7-en-3-ol as a yellow oil (337.4 g, 1.006 mmol, 50 %).  
FTIR (ATR): 3413 (br), 3119 (w) 2949 (m), 2867 (m), 1588, 1507, 1473 (m), 1345, 
1308 (s), 1277, 1211, 1100, 1078 (s), 964, 903,767, 746 (m) cm-1. 
1H NMR (500 MHz, CDCl3): δ  7.92 – 7.87 (m, 1H), 5.87 – 5.68 (m, 1H), 4.35 – 
4.30 (m, 1H), 3.22 – 3.12 (m, 1H), 2.34 (t, J = 0.8 Hz, 3H), 2.22 – 2.05 (m, 1H), 
1.76 – 1.64 (m, 0H), 1.58 – 1.35 (m, 1H), 1.32 – 1.19 (m, 1H), 0.89 (s, 4H) ppm.  
13C NMR (125 MHz, CDCl3): δ 161.5, 143.4, 136.2, 132.6, 125.0, 124.2, 124.1, 




Preparation of 2,2-dimethylhept-6-en-3-ol 
 
Notebook Reference: RDLA223 
An oven dried 100 mL 2-neck round bottom flask with stir bar was charged 
with magnesium turnings (1.0338 g, 42.534 mmol) and fitted with a reflux 
condenser and placed under argon. THF (15 mL) was added via syringe followed 
by dibromoethane (4 drops) and allowed to stir for 10 mins in order to activate the 
magnesium. 4-bromo-1-butene (2.58 mL, 23.0 mmol) was diluted in 10 mL and 
added drop wise over 15 minutes. The reaction was then heated at reflux for 1 
hour. The reaction was cooled to room temperature and pivaldehyde (2.00 mL, 
18.4 mmol) was added via syringe and the reaction was heated at reflux for 2 hours. 
The reaction was cooled to room temperature, poured over 10% HCl (50 mL), 
extracted with ether (3 × 30 mL), dried over magnesium sulfate, and concentrated 
in vacuo. The resultant crude oil was purified via flash chromatography (6:1 
Hex:EtOAc, Rf = 0.40) to afford a clear, colorless oil (1.2454  g,  8.76 mmol, 48 %). 
FTIR (ATR): 3382 (br), 3078 (w), 2952, 2869 (m), 1449 (s), 1393, 1364 (s), 1075, 
1005 (s), 909 (s) cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.83 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 5.02 (dq, J = 
17.1, 1.7 Hz, 1H), 4.96 (ddt, J = 10.2, 2.3, 1.3 Hz, 1H), 3.19 (dq, J = 10.6, 1.9 Hz, 
1H), 2.18 – 2.01 (m, 2H), 1.75 – 1.63 (m, 1H), 1.54 (dddd, J = 13.5, 10.1, 6.0, 1.9 
Hz, 2H), 1.50 – 1.34 (m, 1H), 1.33 – 1.19 (m, 1H), 0.90 (d, J = 0.7 Hz, 9H) ppm. 




Preparation of 2,2-dimethylhept-6-en-3-ol 
 
Notebook Reference: RDLB160 
An oven dried 50 mL tube with stir bar was charged with magnesium 
turnings (729.2 mg, 30.00 mmol) and placed under argon. THF (15 mL) was added 
via syringe and 5-bromo-1-butene (1.74 mL, 15.0  mmol) was diluted in 10 mL and 
added drop wise over 15 minutes. The reaction was then heated at reflux for 1 
hour. The reaction was cooled to 0 ˚C and benzaldehyde (1.02 mL, 10.00  mmol) 
was added dropwise via syringe and allowed to warm to room temperature over 2 
hours. The reaction was quenched with 10% HCl (50 mL), extracted with ether (3 
× 30 mL), dried over magnesium sulfate, and concentrated in vacuo. The resultant 
crude oil was purified via flash chromatography (9:1 Hex:EtOAc, Rf = 0.3 in 9:1 
Hex:EtOAc) to afford a clear, colorless oil (1.5251  g,  8.65 mmol, 87 %). 
FTIR: 3345 (br), 3063, 3028 (w), 2934, 2860 (w), 1449 (s), 1393, 1364 (s), 1075, 
1005 (s), 909 (s) cm-1. 
1H NMR (CDCl3, 500 MHz): δ 7.37 (s, 2H), 7.44 – 7.26 (m, 2H), 5.81 (ddt, J = 16.9, 
10.2, 6.7 Hz, 1H), 5.06 – 4.94 (m, 2H), 4.71 (ddd, J = 8.1, 5.7, 2.6 Hz, 1H), 2.15 – 
2.05 (m, 2H), 1.92 – 1.66 (m, 3H), 1.62 – 1.50 (m, 1H), 1.42 (ddtd, J = 13.1, 10.5, 
7.4, 5.6 Hz, 1H) ppm. 





Preparation of (E)-7-hydroxy-7-phenylhept-2-en-1-yl acetate 
 
Notebook Reference: RDLB174 
Grubbs 2nd generation catalyst (90.3 mg, 0.106 mmol) and p-benzoquinone 
(57.5 mg, 0.532 mmol) were charged in a flame dried 25 mL flask with stir bar and 
placed under argon. Anhydrous DCM (10 mL) was added via syringe, followed by 
a mixture of 4-20a and Z-1,4-diacetoxy-2-butene. The syringe was rinsed twice 
with DCM into the flask. A reflux condenser was fitted to the flask and the reaction 
was heated at reflux overnight. The reaction was cooled to room temperature, 
filtered through a plug of silica, rinsed with EtOAc, and concentrated in vacuo. The 
crude oil was purified by flash chromatography (6-3:1 Hex:EtOAc,Rf = 0.16 in 3:1 
Hex:EtOAc). E:Z ratio determined to be 5:1 by comparison of 1H NMR chemical 
shifts at 4.49 and 4.59 ppm. 
FTIR: 3345 (br), 3063, 3028 (w), 2934, 2860 (w), 1736 (s), 1453, 1381, 1386 (w), 
1228, 1023 (s), 968, 700 (m) cm-1. 
1H NMR (CDCl3, 300 MHz): δ 7.33 (s, 2H), 7.42 – 7.19 (m, 2H), 5.82 – 5.63 (m, 
1H), 5.67 – 5.46 (m, 1H), 4.67 (s, 1H), 4.73 – 4.55 (m, 1H), 4.49 (dt, J = 6.4, 1.0 
Hz, 2H), 2.21 – 2.00 (m, 3H), 2.04 (s, 2H), 1.85 (s, 1H), 2.00 – 1.22 (m, 4H) ppm. 
13C NMR (CDCl3, 75 MHz):  δ 170.85, 144.69, 135.95, 134.92, 128.46, 127.57, 
125.84, 124.18, 123.66, 74.45, 74.38, 65.17, 60.27, 38.44, 32.05, 27.26, 25.53, 





Preparation of undeca-1,10-dien-6-ol 
 
Notebook Reference: RDLB178 
An oven dried 100 mL 2-neck round bottom flask with stir bar was charged 
with magnesium turnings (1.5191g, 62.50 mmol) and fitted with a reflux condenser 
and placed under argon. THF (20 mL) was added via syringe followed by 
dibromoethane (4 drops) and allowed to stir for 10 mins in order to activate the 
magnesium. 5-bromo-1-pentene (6.51 mL, 55.0 mmol) was diluted in 10 mL and 
added drop wise over 15 minutes. The reaction was then heated at reflux for 1 
hour. The reaction was cooled to room temperature and ethyl formate (2.02 mL, 
25 mmol) was added via syringe and the reaction was heated at reflux for 2 hours. 
The reaction was cooled to room temperature, poured over 10% HCl (100 mL), 
extracted with ether (3 × 50 mL), dried over magnesium sulfate, and concentrated 
in vacuo. The resultant crude oil was purified via flash chromatography (6:1 
Hex:EtOAc, Rf = 0.34) to afford a clear, colorless oil (3.5806 g, 21.278 mmol, 85%). 
FTIR (ATR): 3330 (br), 3076, 2977 (w), 2930, 2859 (m), 1641, 1458, 1440, 1415 
(m), 1324 (w), 933, 907, 826 (s) cm-1. 
1H NMR (500 MHz, CDCl3): δ  5.84 (ddt, J = 17.0, 10.2, 6.7 Hz, 2H), 5.08 – 4.95 
(m, 4H), 3.64 (q, J = 6.5, 5.1 Hz, 1H), 2.18 – 2.03 (m, 4H), 1.71 – 1.38 (m, 9H), 
1.35 – 1.25 (m, 1H) ppm. 




Preparation of (2E,11E)-7-hydroxytrideca-2,11-diene-1,13-diyl diacetate 
 
Notebook Reference: RDLA198 
An oven dried 100 mL round bottom flask with a stir bar was charged with 
p-benzoquinone (104.3 mg, 0.9652 mmol) and Grubbs 2nd Generation Catalyst 
(273.1 mg, 0.3217 mmol) and placed under argon. DCM (30 mL) was added via 
syringe followed by (Z)-but-2-ene-1,4-diacetoxy (20.52 mL, 128.7 mmol) and 
undeca-1,10-dien-6-ol (2.707 g, 16.09 mmol). The reaction was stirred at room 
temperature for 3 days. The reaction mixture was concentrated in vacuo, and 
purified via flash chromatography (2:1 Hex:EtOAc, Rf = 0.21) to afford a colorless 
oil (2.328 g, 13.834 mmol, 86%). E:Z ratio determined to be 6:1 by comparison of 
1H NMR chemical shifts at 4.49 and 4.59 ppm. 
FTIR (ATR): 3459 (br), 2933 (w), 1736 (s), 1442, 1363 (w), 1226, 1023 (s), 965 
(m) cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.78 (dtt, J = 15.7, 6.7, 1.2 Hz, 2H), 5.69 – 5.52 (m, 
2H), 4.56 – 4.49 (m, 4H), 3.61 (s, 1H), 2.23 – 2.03 (m, 10H), 1.63 – 1.47 (m, 4H), 
1.50 – 1.37 (m, 4H) ppm. 





Preparation of (2E,11E)-trideca-2,11-diene-1,7,13-triol 
 
Notebook Reference: RDLA255 
Potassium hydroxide (392.8, 7.000 mmol) was charged in a 25 mL round 
bottom flask with a stir bar and absolute ethanol was added. Deionized water (2 
mL) was added until the potassium hydroxide became soluble. (2E,11E)-7-
hydroxytrideca-2,11-diene-1,13-diyl diacetate (624.8 mg, 2.000 mmol) was diluted 
in 1 mL ethanol and added to the solution. The solution was allowed to stir for 1h 
and monitored for consumption of starting material by TLC. After 1h, when all the 
starting material had been consumed the reaction mixture was poured over a 
saturated sodium chloride solution (50 mL), extracted with ethyl actate (3 × 30 mL), 
dried over MgSO4, and concentrated in vacuo. The crude product was purified via 
column chromatography (0-5% EtOH/EtOAc) to afford a white solid (450.4 mg, 
1.972 mmol, 99%) 
FTIR (ATR): 3301 (br), 2927 (m), 2856 (m), 1437 (w), 1175, 1084 (m`), 966, 910 
cm-1. 
1HNMR (500 MHz, CDCl3): δ 5.74 – 5.63 (m, 4H), 4.09 (dd, J = 5.1, 2.7 Hz, 4H), 
3.60 (s, 1H), 2.20 – 2.01 (m, 4H), 1.79-1.12 (m, 8H). 







Notebook Reference: RDLA258 
An oven dried 50 mL flask with a stir bar was charged with 
triphenylphosphine (725.1 mg, 2.765 mmol) and 2,6-dimethyl-4-nitrophenol (483.3 
mg, 2.891 mmol), and placed under argon. Dry THF (10 mL) was added to the 
flask via syringe followed by 4-29 (287 mg, 1.25 mmol). The reaction flask was 
cooled to -78° C (dry ice/acetone bath). DIAD (0.57 mL, 2.9 mmol) was diluted with 
dry THF (10 mL) and added dropwise over 15 minutes. The reaction was stirred 
for 48 h. The reaction mixture was diluted with ether, washed with 10% NaOH 
solution (3 × 30 mL) and dried over anhydrous magnesium sulfate. The mixture 
was gravity filtered, and concentrated in vacuo. The crude product was purified via 
column chromatography (2:1 Hex:EtOAc) to give a pale, yellow solid (402.3 mg, 
1.159  mmol, 67 %). 
FTIR (ATR):  
1H NMR (500 MHz, CDCl3): δ 7.91 (dh, J = 1.3, 0.6 Hz, 2H), 5.90 – 5.66 (m, 2H), 
5.08 – 4.88 (m, 6H), 4.32 (d, J = 5.3 Hz, 2H), 3.60 (s, 1H), 2.43 – 2.26 (m, 7H), 
2.21 – 2.02 (m, 3H), 1.53 – 1.10 (m, 4H), 1.26 (s, 2H) ppm 
13C NMR (125 MHz, CDCl3): δ   
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Gold-Catalyzed Cyclization of (E)-6-cyclohexylhex-2-ene-1,6-diol 
 
Notebook Reference: RDLA241 
A flame dried 10 mL culture tube with stir bar was charged with AgOTf (31.6 
mg, 0.150 mmol). AuCl3 (12.4 mg, 0.0500 mmol) was added by scoring the tip of 
a 50 μL micropipette loading the solid in the tip and breaking the tip into the reaction 
tube. Basic alumina (10 mg) was added to reaction tube to adsorb water and any 
HCL in solution. Deuterochloroform (2 mL) was added via syringe. The mixture 
was allowed to stir for 1 h, after which (E)-1-cyclohexyl-6-(2,6-dimethyl-4-
nitrophenoxy)hex-4-en-1-ol  (142 mg, 0.500 mmol) was diluted in 
deuterochloroform (1 mL) and added via syringe. The reaction progress was 
monitored by NMR, after 24 h presence of products and absence of starting 
material indicated the reaction had ended with nearly complete conversion. The 
reaction mixture was filtered through a short plug of silica gel, and concentrated in 
vacuo. The crude product was purified via column chromatography (30:1 
Hex:EtOAc, Rf = 0.29). Fractions containing the major product were collected and 
concentrated in vacuo to afford a clear, colorless oil (36.2 mg, 0.047 mmol, 40%). 
Fractions containing the minor product were collected and concentrated in vacuo 
to yield a clear, colorless oil (10.1 mg, 11 %). 
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Transient 1D-NOESY was performed with selective excitations of the 
protons at 3.78 ppm and 3.06 ppm. Diaxial interactions were observed indicating 
the constituent of the major product is the cis-isomer.  
Based on the yields of the diastereomers the diastereotopic ratio was determined 
to be 4:1. 
FTIR (ATR): 2922 (s), 2851 (s), 1646, 1450, 1409, 1360 (w), 1203, 1075, 1013 (s), 
987, 917, 888 (s) cm-1. 
1HNMR (500 MHz, CDCl3, Major Product): δ  5.87 (ddd, J = 17.4, 10.7, 5.2, 1H), 
5.23 (ddd, J = 17.3, 1.7, 1.7, 1H), 5.06 (ddd, , J = 10.7, 1.7, 1.7, 1H), 3.78 (ddddd, , 
J = 11.2, 5.2, 1.6, 1.6, 1.6, 1H), 3.06 (ddd, J = 11.2, 6.8, 2.1,1H),  1.96 (m, 1H), 
1.87 (dddd, J = 13.4, 6.7, 3.9, 2.6, 1H), 1.75-0.81 (m, 13H) ppm. 
13CNMR (125MHz, CDCl3, Major Product): δ 139.9, 113.9, 82.1, 43.2, 31.7, 29.3, 
28.7, 27.1 ppm. 
1HNMR (500 MHz, CDCl3, Minor Product): δ  5.88 (dddd, J = 17.5, 10.9, 4.3, 0.8, 
1H), 5.18 (m, 1H), 4.33 (dddd, , J = 6.2, 4.1, 4.9, 1.9, 1H), 3.35 (ddd, J = 11.0, 8.3, 
3.1, 1H),  1.92 (m, 1H), 1.73 (m, 3H), 1.66-1.53 (m, 7H), 1.44 (dddd, J = 18.4, 11.5, 
3.9, 1H), 1.36 (dddd, J = 13.4, 9.9, 9.9, 4.2, 1H), 1.29-1.07 (m, 6H), 0.98-0.82 (m, 
4H) ppm. 
13CNMR (125MHz, CDCl3, Minor Product): δ 139.1, 115.6, 75.4, 72.3, 41.0, 29.1, 




Gold-Catalyzed Cyclization of (E)-8,8-dimethylnon-2-ene-1,7-diol 
 
Notebook Reference: RDLA251 
A flame dried 10 mL culture tube with stir bar was charged with AgOTf (38.5 
mg, 0.150 mmol). AuCl3 (15.2, 0.0500 mmol) was added by scoring the tip of a 50 
μL micropipette loading the solid in the tip and breaking the tip into the reaction 
tube. Basic alumina (10 mg) was added to reaction tube to adsorb water and any 
HCL in solution. Deuterochloroform (2 mL) was added via syringe. The mixture 
was allowed to stir for 1 h, after which (E)-8,8-dimethylnon-2-ene-1,7-diol (0.500 
mmol) was diluted in deuterochloroform (1 mL) and added via syringe. The 
reaction progress was monitored by NMR, after 24 h presence of products and 
absence of starting material indicated the reaction had ended with nearly complete 
conversion. The reaction mixture was filtered through a short plug of silica gel, and 
concentrated in vacuo. The crude product was purified via column chromatography 
(19:1 Hex:EtOAc, Rf = 0.41). Fractions containing the pure product were collected 
and concentrated in vacuo to afford a clear, colorless oil (78.6 mg, 0.4671 mmol, 
93 %).  
Transient 1D-NOESY was performed with selective excitations of the 
protons at 3.78 ppm and 2.95 ppm. Diaxial interactions were observed indicating 




FTIR (ATR): 2956, 2920 (s), 2870 (m), 1521, 1458, 1341 (m), 1263, 1208, 1150, 
1097 (s), 1026, 969 (s) cm-1. 
1HNMR (500 MHz, CDCl3): δ  5.86 (ddd, J = 17.3, 10.7, 4.6 Hz, 1H), 5.24 (dt, J = 
17.3, 1.9 Hz, 1H), 5.03 (ddd, J = 10.7, 2.0, 1.6 Hz, 1H), 3.78 (dtd, J = 11.4, 4.0, 1.9 
Hz, 1H), 2.95 (dd, J = 11.3, 1.9 Hz, 1H), 1.92 – 1.83 (m, 1H), 1.65 – 1.42 (m, 4H), 
1.29 – 1.13 (m, 2H), 0.90 (s, 9H) ppm. 





Gold-Catalyzed Cyclization of (E)-8,8-dimethylnon-2-ene-1,7-diol 
 
Notebook Reference: RDLB172 
A flame dried 10 mL culture tube with stir bar was charged with AgOTf (1.9 
mg, 0.0075 mmol). AuCl3 (0.8 mg, .00025 mmol) was added by scoring the tip of 
a 50 μL micropipette loading the solid in the tip and breaking the tip into the reaction 
tube. MS 4 Å (6 mg). DCM (1 mL) was added via syringe. The mixture was allowed 
to mix for 1 h, after which 4-21a (51.6 mg, 0.250 mmol) added via syringe. Reaction 
progress monitored by GC. The reaction mixture was filtered through a short plug 
of silica gel, and concentrated in vacuo. The crude product was purified via column 
chromatography (19:1 Hex:EtOAc, Rf = 0.41). Fractions containing the pure 
product were collected and concentrated in vacuo to afford a clear, colorless oil. 
Diastereomeric ratio determined to be 4:1 by GC using biphenyl as an internal 
reference. 
FTIR (ATR): 3024, 2956, 2920 (w) cm-1. 
1H NMR (CDCl3, 300 MHz): δ 7.37 (tdd, J = 7.3, 6.6, 2.8, 1.4 Hz, 2H), 7.37 – 7.18 
(m, 2H), 6.07 – 5.86 (m, 1H), 5.38 – 5.20 (m, 1H), 5.11 (dt, J = 10.6, 1.5 Hz, 1H), 
4.44 (dd, J = 11.2, 2.2 Hz, 1H), 4.10 – 3.97 (m, 1H), 2.21 – 2.14 (m, 1H), 1.97 
(dtd, J = 12.9, 4.7, 4.1, 2.3 Hz, 1H), 1.91 – 1.78 (m, 1H), 1.84 – 1.63 (m, 2H), 
1.62 – 1.36 (m, 2H), 1.27 (d, J = 3.6 Hz, 1H), 1.02 – 0.80 (m, 1H) ppm. 
13C NMR (CDCl3, 300 MHz):  δ143.3, 139.4, 128.2, 127.2, 125.8, 114.4, 79.7, 




Gold-Catalyzed Cyclization of (E)-1-cyclohexyl-7-(2,6-dimethyl-4-
nitrophenoxy)hept-5-en-1-ol 
 
Notebook Reference: RDLA240 
A flame dried 10 mL culture tube with stir bar was charged with AgOTf (31.6 
mg, 0.123 mmol). AuCl3 (12.4 mg, 0.041 mmol) was added by scoring the tip of a 
50 μL micropipette loading the solid in the tip and breaking the tip into the reaction 
tube. Basic alumina (10 mg) was added to reaction tube to adsorb water and any 
HCL in solution. Deuterochloroform (2 mL) was added via syringe. The mixture 
was allowed to stir for 1 h, after which (E)-1-cyclohexyl-6-(2,6-dimethyl-4-
nitrophenoxy)hex-4-en-1-ol (142 mg, 0.410 mmol) was diluted in 
deuterochloroform (1 mL) and added via syringe. The reaction progress was 
monitored by NMR, and after 24 h presence of products and absence of starting 
material indicated the reaction had proceeded with nearly complete conversion. 
The reaction mixture was filtered through a short plug of silica gel, and 
concentrated in vacuo. The crude product was purified via column chromatography 
(19:1 Hex:EtOAc, Rf = 0.39). Fractions containing the pure product were collected 
and concentrated in vacuo to afford a clear, colorless oil (9.1 mg, 0.050 mmol, 
12 %). Fractions containing the major product and inseparable minor product were 
collected and concentrated in vacuo to yield a clear, colorless oil mixture of two 
diastereomers (60.2 mg, 0.334 mmol, 81%, dr 6:1). Fraction 1 was determined to 
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be the cis diastereomer by dipolar interactions present in 1D-NOESY with selective 
excitations at 3.78 ppm and 3.06 ppm. GC-MS analysis in combination with 
isolated yields determined the total diasteremeric ratio to be 7:1. (Calculated yield 
of products from collection of data is 69.3 g, 0.357 mmol, 93 %) 
FTIR (ATR): 2922 (s), 2851 (s), 1646, 1450, 1409, 1360 (w), 1203, 1075, 1013 (s), 
987, 917, 888 (s) cm-1. 
1HNMR (500 MHz, CDCl3, Major Product): δ  5.87 (ddd, J = 17.3, 10.6, 5.1 Hz, 0H), 
5.23 (dt, J = 17.3, 1.7 Hz, 0H), 5.06 (dt, J = 10.6, 1.6 Hz, 0H), 3.78 (ddt, J = 13.1, 
5.3, 1.8 Hz, 1H), 3.06 (ddd, J = 11.2, 6.7, 2.0 Hz, 1H), 1.96 (dtq, J = 11.9, 3.6, 1.8 
Hz, 1H), 1.95 – 1.82 (m, 1H), 1.76 – 1.68 (m, 1H), 1.72 – 1.61 (m, 1H), 1.62 (ddd, 
J = 5.0, 3.8, 2.2 Hz, 1H), 1.61 – 1.44 (m, 1H), 1.47 – 1.33 (m, 1H), 1.34 – 1.15 (m, 
3H), 1.19 – 1.09 (m, 1H), 1.05 – 0.91 (m, 1H), 0.94 – 0.79 (m, 1H) ppm. 





Gold-Catalyzed Cyclization of (E)-9-(2,6-dimethyl-4-nitrophenoxy)-2,2-
dimethylnon-7-en-3-ol 
 
Notebook Reference: RDLA250 
A flame dried 10 mL culture tube with stir bar was charged with AgOTf 
(0.150 mmol). AuCl3 (.0500 mmol) was added by scoring the tip of a 50 μL 
micropipette loading the solid in the tip and breaking the tip into the reaction tube. 
Basic alumina (0.150 mmol) was added to reaction tube to adsorb water and any 
HCL in solution. Deuterochloroform (2 mL) was added via syringe. The mixture 
was allowed to stir for 1 h, after which (E)-9-(2,6-dimethyl-4-nitrophenoxy)-2,2-
dimethylnon-7-en-3-ol (0.500 mmol) was diluted in deuterochloroform (1 mL) and 
added via syringe. The reaction progress was monitored by NMR, after 24 h 
presence of diastereotopic products and absence of starting material indicated the 
reaction had ended with nearly complete conversion. The reaction mixture was 
filtered through a short plug of silica gel, and concentrated in vacuo. The crude 
product was purified via column chromatography (19:1 Hex:EtOAc, Rf = 0.40). 
Fractions containing the pure product were collected and concentrated in vacuo to 
afford a clear, colorless oil (19.3 mg, .1147 mmol, 23%). Fractions containing the 
major product and inseparable minor product were collected and concentrated in 
vacuo to yield a clear, colorless oil mixture of two compounds (53.7 mg). Fraction 
1 was determined to be the cis diastereomer by diaxial interactions present in 1D-
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NOESY with selective excitations at 3.78 ppm and 2.95 ppm. GC-MS analysis in 
combination with isolated yields determined the total diastereomeric ratio to be 
99:1. (Calculated yield of products from collection of data is 73.0 g, 0.434 mmol, 
87 %). 
FTIR (ATR): 2956, 2920 (s, CvinylH stretch), 2870 (m, CalkylH stretch), 1521, 1458, 
1341 (m, CalkylH bend), 1263, 1208, 11250, 1097 (s, CO stretch), 1026, 969 (s, 
CvinylH oop bend) cm-1. 
1HNMR (500 MHz, CDCl3): δ  5.86 (ddd, J = 17.3, 10.7, 4.6 Hz, 1H), 5.24 (dt, J = 
17.3, 1.9 Hz, 1H), 5.03 (ddd, J = 10.7, 2.0, 1.6 Hz, 1H), 3.78 (dtd, J = 11.4, 4.0, 1.9 
Hz, 1H), 2.95 (dd, J = 11.3, 1.9 Hz, 1H), 1.92 – 1.83 (m, 1H), 1.65 – 1.42 (m, 4H), 
1.29 – 1.13 (m, 2H), 0.90 (s, 9H) ppm. ppm. 






Gold-Catalyzed Cyclization of (2E,11E)-7-hydroxytrideca-2,11-diene-1,13-
diyl diacetate 
 
Notebook Reference: RDLA160 
A flame dried 10 mL culture tube with stir bar was charged with AuCl3 (11.6 
mg, 0.250 mmol) and AgOTf (19.3 mg, 0.0750 mmol) and placed under argon. 
Deuterochloroform (2 mL) was added via syringe. The mixture was allowed to stir 
for 1 h, after which (2E,11E)-7-hydroxytrideca-2,11-diene-1,13-diyl diacetate 
(156.1 mg, 0.500 mmol) was diluted in deuterochloroform (1 mL) and added via 
syringe. The reaction progress was monitored by NMR, and after 24 h presence 
of products and absence of starting material indicated the reaction had completed 
with nearly complete conversion. The reaction mixture was filtered through a short 
plug of silica gel, and concentrated in vacuo. The crude product was purified via 
column chromatography (12:1 Hex:EtOAc, Rf = 0.70) to afford a clear, colorless oil 
(0.0966 g, 0.406 mmol, 81%). The diastereomeric ratio was determined by NMR 
using the ratio of 2 and 6 proton chemical shifts of the major (3.32 and 3.80 ppm) 
and minor diastereomers (3.67 and 4.33 ppm) to determine a diastereomeric ratio 
of 7:1. The confirmation of these diastereomers was determined by 1D-NOESY 
with selective excitation of the chemical shifts 3.82 and 3.80 ppm. 
FTIR (ATR): 2934 (m), 2859 (m), 1739 (s), 1440 (w), 1363 (w), 1127 (s), 1076 (s), 
1023 (s), 966, 917 cm-1. 
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1HNMR (500 MHz, CDCl3): δ  5.93 – 5.81 (m, 1H), 5.77 (dtt, J = 15.7, 6.7, 1.2 Hz, 
1H), 5.56 (dtt, J = 15.4, 6.5, 1.5 Hz, 1H), 5.27 – 5.16 (m, 1H), 5.07 (dt, J = 10.6, 
1.6 Hz, 1H), 4.50 (dp, J = 6.5, 1.1 Hz, 2H), 3.85 – 3.76 (m, 1H), 3.32 (dddd, J = 
11.0, 7.0, 5.0, 1.9 Hz, 1H), 2.16 – 2.02 (m, 2H), 2.06 (s, 3H), 1.85 (dtt, J = 13.4, 
5.4, 2.0 Hz, 1H), 1.71 – 1.36 (m, 6H), 1.37 – 1.12 (m, 2H)) ppm. 
13CNMR (125MHz, CDCl3): δ 170.9, 139.7, 136.4, 123.9, 114.3, 78.2, 76.8, 65.3, 




Gold-Catalyzed Cyclization of (2E,11E)-trideca-2,11-diene-1,7,13-triol 
 
Notebook Reference: RDLA256 
A flame dried 10 mL culture tube with stir bar was charged with AgOTf (38.5 
mg, 0.150 mmol). AuCl3 (15.2 mg, 0.0500 mmol) was added by scoring the tip of 
a 50 μL micropipette loading the solid in the tip and breaking the tip into the reaction 
tube. Basic alumina (10 mg) was added to reaction tube to adsorb water and any 
HCL in solution. Deuterochloroform (2 mL) was added via syringe. The mixture 
was allowed to stir for 1 h, after which (2E,11E)-trideca-2,11-diene-1,7,13-triol 
(0.500 mmol) was diluted in deuterochloroform (1 mL) and added via syringe. The 
reaction progress was monitored by NMR, and after 24 h presence of products 
and absence of starting material indicated the reaction had completed with nearly 
complete conversion. The reaction mixture was filtered through a short plug of 
silica gel, and concentrated in vacuo. The crude product was purified via column 
chromatography (15:1 Hex:EtOAc, Rf =0.32) to afford a clear, colorless oil (99 mg, 
94%). The diastereomeric ratio was determined by NMR using the ratio of 2 and 6 
proton chemical shifts of the major (3.32 and 3.80 ppm) and minor diastereomers 
(3.67 and 4.33 ppm) to determine a diastereomeric ratio of 4:1. The relative 
confirmation of these diastereomers was determined by 1D-NOESY with selective 
excitation of the chemical shifts 3.82 and 3.80 ppm. 
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FTIR (ATR): 2934 (m, CvinylH stretch), 2859 (m, CalkylH stretch), 1739 (s, ester 
carbonyl CO stretch), 1440 (w, CvinylH oop bend), 1363 (w, CvinylH stretch), 1127 
(s, CO stretch), 1076 (s, CO stretch), 1023 (s, CO stretch), 966, 917 cm-1. 
1HNMR (500 MHz, CDCl3): δ 5.98 – 5.78 (m, 0H), 5.32 – 5.15 (m, 1H), 5.14 – 5.00 
(m, 1H), 3.77 (ddq, J = 11.1, 5.4, 2.0 Hz, 1H), 3.06 (ddd, J = 11.2, 6.7, 2.0 Hz, 1H), 
2.01 – 1.79 (m, 2H), 1.71 (s, 3H), 1.70 – 1.49 (m, 5H), 1.54 – 1.33 (m, 1H), 1.39 – 
1.20 (m, 1H), 1.25 (s, 1H), 1.25 – 1.11 (m, 2H), 0.98 (dtdd, J = 31.2, 15.8, 11.4, 
7.1 Hz, 3H) ppm. 
13CNMR (125MHz, CDCl3): δ 170.9, 139.7, 136.4, 123.9, 114.3, 78.2, 76.8, 65.3, 




Gold-Catalyzed Cyclization of (2E,11E)-1,13-bis(2,6-dimethyl-4-
nitrophenoxy)trideca-2,11-dien-7-ol  
 
Notebook Reference: RDLA264 
A flame dried 10 mL culture tube with stir bar was charged with AgOTf 
(38.5mg, 0.1500 mmol) and basic alumina (10 mg). AuCl3 (15.2 mg, 0.0500 mmol) 
was massed into the tip of a scored micropipette, broken off into the tube and 
placed under argon. Deuterochloroform (1 mL) was added via syringe. The mixture 
was allowed to stir for 1 h, after which (2E,11E)-1,13-bis(2,6-dimethyl-4-
nitrophenoxy)trideca-2,11-dien-7-ol (263.3 mg, 0.500 mmol) was diluted in 
deuterochloroform (1 mL) and added via syringe. The reaction progress was 
monitored by NMR, and after 24 h presence of products and absence of starting 
material indicated the reaction had completed with nearly complete conversion. 
The reaction mixture was filtered through a short plug of silica gel, and 
concentrated in vacuo. The crude product was purified via column chromatography 
(15:1 Hex:EtOAc, Rf = 0.28) to afford a clear, slight yellow oil (21.6 mg, 12%) as a 
single diastereomer.  
FTIR (ATR): 2956, 2920 (s), 2870 (m), 1521, 1458, 1341 (m), 1263, 1208, 11250, 
1097 (s), 1026, 969 (s) cm-1.  
1HNMR (500 MHz, CDCl3): δ 7.91 (s, 1H), 5.95 – 5.64 (m, 1H), 5.29 – 5.14 (m, 
0H), 5.13 – 5.00 (m, 0H), 4.31 (t, J = 4.9 Hz, 1H), 3.86 – 3.74 (m, 1H), 3.39 – 3.25 
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(m, 1H), 2.41 – 2.27 (m, 3H), 2.10 (q, J = 6.5 Hz, 1H), 1.84 (dq, J = 9.9, 3.9, 3.0 
Hz, 1H), 1.57 (s, 3H), 1.51 (s, 1H), 1.76 – 1.12 (m, 2H), 0.85 (s, 3H) ppm. 
13CNMR (125MHz, CDCl3): δ 139.6, 136.4, 132.6, 124.8, 124.1, 114.3, 78.2, 77.5, 




Catalyst Loading and Control Experiments in the Gold-Catalyzed Cyclization 
to Form 2-phenyl-6-vinyltetrahydro-2H-pyran 
 
Notebook Reference: RDLB172 
To a 2 mL vial was charged catalyst at the specified loading, internal 
reference biphenyl (19.3 mg, 0.125 mmol) and additive MS 4 Å (if specified, 20 % 
w/w). Anhydrous DCM (1 mL) was added via syringe and the catalyst was allowed 
to from over 30 minutes at room temperature. Substrate 4-21a (51.6 mg, 0.250 
mmol) was massed into a syringe and added to the reaction vessel by mixing 
solution four times by mixing within the syringe. Every 10 minutes for 40 minutes 
an aliquot (25 L) was removed from the reaction solution and passed through a 
short plug of silica and rinsed with DCM directly into a GC sample vial. Using the 
same procedure aliquots were taken at 4 hours and 24 hours. Samples were 
analyzed by GC-MS against known sample retention factors. See Table 4-2 for 
results. 
FTIR (ATR): 3024, 2956, 2920 (w) cm-1. 
1H NMR (CDCl3, 300 MHz): δ 7.37 (tdd, J = 7.3, 6.6, 2.8, 1.4 Hz, 2H), 7.37 – 7.18 
(m, 2H), 6.07 – 5.86 (m, 1H), 5.38 – 5.20 (m, 1H), 5.11 (dt, J = 10.6, 1.5 Hz, 1H), 
4.44 (dd, J = 11.2, 2.2 Hz, 1H), 4.10 – 3.97 (m, 1H), 2.21 – 2.14 (m, 1H), 1.97 
(dtd, J = 12.9, 4.7, 4.1, 2.3 Hz, 1H), 1.91 – 1.78 (m, 1H), 1.84 – 1.63 (m, 2H), 
1.62 – 1.36 (m, 2H), 1.27 (d, J = 3.6 Hz, 1H), 1.02 – 0.80 (m, 1H) ppm. 
13C NMR (CDCl3, 300 MHz):  δ143.3, 139.4, 128.2, 127.2, 125.8, 114.4, 79.7, 




Analysis of Solvent Effects in the Gold-Catalyzed Cyclization to Form 2-
phenyl-6-vinyltetrahydro-2H-pyran 
 
Notebook Reference: RDLB178 
To a 2 mL vial were charged biphenyl (19.3mg, 0.125 mmol), AuCl3 (0.4 mg, 
0.00125 mmol), and AgOTf (1.0 mg, 0.00375 mmol). Solvent (0.5 mL) was added 
via syringe and catalyst was allowed to form over 30 minutes at room temperature. 
Substrate 4-24 (31.0 mg, 0.125 mmol) was massed into a syringe and added to 
the reaction by mixing the syringe 4 times. Every 10 minutes for 40 minutes an 
aliquot (20 L) was removed, filtered through a plug of silica and rinsed with DCM 
directly into a GC sample vial. A final aliquot was obtained using the same method 
after 12 hours. Samples were analyzed by GC-MS against known sample retention 
factors. See Table 4-3 for results. 
FTIR (ATR): 3024, 2956, 2920 (w) cm-1. 
1H NMR (CDCl3, 300 MHz): δ 7.37 (tdd, J = 7.3, 6.6, 2.8, 1.4 Hz, 2H), 7.37 – 7.18 
(m, 2H), 6.07 – 5.86 (m, 1H), 5.38 – 5.20 (m, 1H), 5.11 (dt, J = 10.6, 1.5 Hz, 1H), 
4.44 (dd, J = 11.2, 2.2 Hz, 1H), 4.10 – 3.97 (m, 1H), 2.21 – 2.14 (m, 1H), 1.97 
(dtd, J = 12.9, 4.7, 4.1, 2.3 Hz, 1H), 1.91 – 1.78 (m, 1H), 1.84 – 1.63 (m, 2H), 
1.62 – 1.36 (m, 2H), 1.27 (d, J = 3.6 Hz, 1H), 1.02 – 0.80 (m, 1H) ppm. 
13C NMR (CDCl3, 300 MHz):  δ143.3, 139.4, 128.2, 127.2, 125.8, 114.4, 79.7, 





Preparation of 5-hydroxy-N-methoxy-N-methylpentanamide 
 
Notebook Reference: RDLB068 
To a suspension of 𝛿-valerolactone (0.65 mL, 6.955 mmol) and N,O -
dimethylhydroxyamine hydrochloride (1.695g, 17.38 mmol) in 50 mL THF at -20 °C 
was added dropwise over a period of 30 minutes a solution of iPrMgCl (25 mL, 
38.25 mmol). The mixture was stirred at -20 °C for 2 hours, then quenched with 25 
mL of saturated NH4Cl solution. The layers were separated and the aqueous layer 
was extracted three times with EtOAc. The combined organic layers were washed 
with brine, dried with anhydrous MgSO4 and concentrated in vacuo. The crude 
product was purified by filtration through plug of silica with EtOAc to yield the 5-
hydroxy-N-methoxy-N-methylpentanamide as colorless oil (472.9 mg, 42%, Rf = 
0.3 in EtOAc) that satisfactorily matched previously previously reported data. 
FTIR (ATR): 3405 (br), 2938, 2870 (m), 1637 (s), 1417 (m), 1386, 1324 (m), 1179 
(s) cm-1  
1H NMR (500 MHz, CDCl3)  3.7 – 3.6 (m, 3H), 3.2 (s, 2H), 2.5 (t, J = 7.2 Hz, 1H), 
1.7 (dtd, J = 8.2, 7.4, 6.6 Hz, 1H), 1.7 – 1.6 (m, 2H) ppm. 







Notebook Reference: RDLB070 
To a solution of the alcohol (459.9 mg, 2.853 mmol) in 30 mL of DCM at 
0 °C was added imidazole (427.3 mg, 6.277mmol) followed by TBSCl (473.0 mg, 
3.138 mmol). The mixture was allowed to warm to room temperature and stirred 
overnight. The reaction was quenched with 10 mL H2O. The layers were separated 
and the aqueous layer was extracted three times with DCM. The combined organic 
layers were washed with 1N HCl (15mL), saturated NaHCO3 (15 mL) and finally 
with brine (15 mL), dried with anhydrous MgSO4 and concentrated in vacuo. The 
crude product was purified by flash chromatography (hexanes to 15% EtOAc in 
hexanes) to yield 2.07g of (93%) of colorless oil that satisfactory matched all 
previously reported data. 
FTIR (ATR): 3035, 2923, 2854 (w), 1586 (w), 1576, 1485,1466, 1456 (s) cm-1. 
1H NMR (300 MHz, CDCl3) 3.70 – 3.52 (m, 5H), 3.13 (s, 3H), 3.12 (s, 2H), 2.40 (t, 
J = 7.4, 2H), 1.73 – 1.43 (m, 4H), 0.90 (s, 9H), 0.00 (s, 6H) ppm. 




Preparation of 1-((tert-butyldimethylsilyl)oxy)dec-9-en-5-one 
 
Notebook Reference: RDLB080 
To an oven dried 50 mL reaction tube with stir bar was charged magnesium 
shavings (160.4 mg, 6.600 mmol), and heated with a heat gun under vacuum (10 
Torr) for 10 minutes, then cooled under argon. Anhydrous THF (2 mL) was added 
via syringe. At room temperature 5-bromopentene (0.39 mL, 3.3 mmol) in THF (2 
mL) was added over the period of 10 minutes. The reaction began to reflux 
indicating Grignard reagent formation, and was stirred for 30 mins after refluxing 
had subsided. The reaction was added dropwise to a solution of 5-((tert-
butyldimethylsilyl)oxy)-N-methoxy-N-methylpentanamide (0.6000 2.200 mmol) in 
THF (4 mL) at -78 °C and stirred for 10 mins, then gradually warmed to 0 °C and 
stirred for 1h. Reaction quenched with water 10 mL, extracted with EtOAc (3×30 
mL), washed with brine (3×30 mL), dried with MgSO4, and concentrated in vacuo. 
Purified by column chromatography (9:1 Hex:EtOAc) to yield a colorless oil (0.2166 
g, 35%) . Rf = 0.47 in 9:1 Hex:EtOAc.  
1H NMR (300 MHz, CDCl3): δ 5.74 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 5.06 – 4.85 
(m, 2H), 3.59 (t, J = 6.2 Hz, 2H), 2.39 (td, J = 7.3, 4.2 Hz, 4H), 2.11 – 1.95 (m, 2H), 
1.74 – 1.40 (m, 6H), 0.87 (s, 9H), 0.02 (s, 6H) ppm 
13C NMR (75 MHz, CDCl3): δ 211.0, 138.0, 115.2, 62.8, 42.6, 41.8, 33.1, 32.27, 







Notebook Reference: RDLB086 
To an oven dried 10 mL tube with stir bar was charged with Grubbs 2nd 
generation catalyst (64.4 mg, 0.0759 mmol) and p-benzoquinone (8.2 mg, 0.0759 
mmol), and placed under argon. DCM (1 mL) added via syringe. Z-2-butene-1,4-
diol (0.37 mL, 4.5 mmol) and alkenone (0.216 g, 0.759 mmol) were mixed and 
diluted into DCM (0.5 mL), then added to the reaction vessel. Reaction stirred 
overnight at rt. Crude mixture purified through short plug of silica, rinsed with 
DCM and concentrated in vacuo. Purified by column chromatography with 2:1 
Hex:EtOAc to yield slightly red oil (145 mg, 60%). 
FTIR (ATR): 3357 (br), 2928(m), 2856 (m), 1711 (s), 1462 (w), 1361, 1253 (w, 
CO stretch), 1095 (m) cm-1. 
1H NMR (300 MHz, CDCl3) δ 5.65 – 5.57 (m, 2H), 4.07 – 4.01 (m, 2H), 3.57 (t, J 
= 6.2 Hz, 2H), 2.43 – 2.33 (m, 4H), 2.06 – 1.94 (m, 2H), 1.76 (s, 1H), 1.69 – 1.53 
(m, 4H), 1.51 – 1.42 (m, 2H), 0.85 (s, 9H), 0.01 (s, 6H) ppm.  
13C NMR (75 MHz, CDCl3) δ 211.0, 132.0, 129.8, 63.5, 62.8, 42.6, 41.8, 32.2, 






Notebook Reference: RDLB092 
To a flame dried 10 mL tube was charged 2,6-dimethyl-4-nitrophenol 
(91.9 mg, 0.550 mmol) and triphenylphosphine (133.7 mg, 0.5100 mmol), and 
placed under argon. 5-18 (145 mg, 0.460 mmol) in THF (1 mL) added via 
syringe. DIAD (0.51 mmol) diluted in THF (1 mL) and added dropwise. Stirred 
room temperature for 48 hours. Reaction mixture diluted with EtOAc, washed 
with 10% NaOH, washed with brine, dried MgSO4, and concentrated in vacuo. 
Purified by column chromatography with 9:1 Hex:EtOAc to yield yellow oil (83.9 
mg, 40%). Rf = 0.27 in 9:1 Hex:EtOAc. 
1H NMR (300 MHz, CDCl3): δ 7.90 (s, 2H), 5.75 (m, 2H), 4.31 (d, J = 4.7, 2H), 
3.60 (t, J = 6.2 Hz, 2H), 2.40 (m, 2H), 2.33 (s, 6H), 2.08 (m, 2H), 1.74-1.44 (m 
6H), 0.88 (s, 9H), 0.03 (s, 6H) ppm. 
13C NMR (75 MHz, CDCl3): δ 210.7, 161.3, 135.4, 132.6, 125.6, 124.2, 73.73, 







Notebook Reference: RDLB096 
To a 10 mL tube was added alkenone (83.9 mg, 0.181 mmol) in THF (1 
mL). TBAF (236.5 mg, 0.905 mmol) added and mixture stirred at room 
temperature overnight. Water (2 mL) added to the reaction vessel, extracted with 
EtOAc, dried over MgSO4 and concentrated in vacuo. Purified by column 
chromatography with 1:1 Hex:EtOAc to yield a yellow oil (16.5 mg, 26 %). 
1H NMR (300 MHz, CDCl3):  7.90 (s, 2H), 5.87 – 5.61 (m, 2H), 4.32 (d, J = 4.0 
Hz, 2H), 3.58 (m, 2H), 2.16 – 1.95 (m, 4H), 2.09 (s, 3H), 1.80 – 1.58 (m, 2H), 
1.50 – 1.28 (m, 1H), 1.25 (s, 1H), 0.97 – 0.78 (m, 1H) ppm. 
13C NMR (75 MHz, CDCl3): δ 210.51, 161.30, 143.40, 135.86, 135.22, 132.52, 
132.50, 126.90, 125.54, 125.19, 124.13, 113.29, 98.67, 73.38, 73.27, 61.37, 
58.95, 42.71, 41.90, 36.53, 32.96, 32.38, 31.62, 29.57, 25.85, 25.31, 24.94, 
22.82, 22.64, 20.92, 18.65, 16.81 ppm.  
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Au(III)-Catalyzed Cyclization of (E)-11-(2,6-dimethyl-4-nitrophenoxy)-1-
hydroxyundec-9-en-5-one 
 
Notebook Reference: RDLB110 
To a flame dried 5 mL scintillation vial with stir bar was charged AuCl3 
(0.001 mmol), AgOTf (0.003 mmol), and basic alumina (10 mg). The reaction 
vessel was placed under argon and 0.2 mL CDCl3 was added via syringe. The 
mixture was heated at 60 ˚C for 1 hour to ensure catalyst formation, then cooled 
to room temperature. Substrate 5-20 was diluted in 0.3 mL CDCl3 and added via 
syringe. Reaction checked by NMR after 24 hours to indicate ~60% conversion of 
substrate to hemiketal 5-21. The reaction was then heated at reflux overnight. No 
observable formation of spiroketal was observed. Reaction was passed through 
a plug of silica, and concentrated in vacuo. The crude mixture was purified by 
MPLC (25 mm Column, 5 mL/min, 1:1 Hex EtOAc) to afford hemiketal susbtrate 
(5.4 mg, 60 %). Diastereomeric ratio estimated from MPLC chromatogram 
approximately (10:1). 
1HNMR (500 MHz, CDCl3): δ 7.92 (s, 2H), 5.75 (m, 2H), 4.33 (d, J = 4.6 Hz, 2H), 






Preparation of 1-(4-methoxyphenyl)hex-5-en-1-ol 
 
Notebook Reference: RDLB078 
To an oven dried 50 mL tube with stir bar was charged magnesium 
shavings (1.823 mg, 75.00 mmol) and place under argon. Anhydrous THF (15 
mL) was added via syringe. 5-bromopentene (4.44 mL, 37.5 mmol) was added 
dropwise via syringe over 15 minutes. Solution generated enough heat to reflux. 
This was allowed to stir for 30 minutes. On the side an oven dried 250 mL round 
bottom flask with addition funnel and stir bar was assembled hot and placed 
under argon to cool.  THF (40 mL) was added by syringe followed by p-
anisaldehyde (3.04 mL, 25.00 mmol). The reaction vessel was cooled to -78 ˚C 
(dry ice/isopropanol bath). The prepared Grignard reagent 6-11 was added via 
cannula to the addition funnel and added dropwise to the solution over 10 
minutes. The reaction vessel was warmed to 0 ˚C and stirred for 1 hour, then 
room temperature for 1 hour. The reaction was quenched with NH4Cl (40 mL) 
added dropwise over 10 minutes. Organics were extracted with EtOAc, washed 
with brine, dried over MgSO4, and concentrated in vacuo to afforded the desired 
compound with slight aldehyde impurity as determined by NMR. The crude 
product was purified by column chromatography (70 mm, 6:1 Hex:EtOAc) to yield 
  
120 
desired product 6-12 as a clear, colorless oil (4.4081, 21.368 mmol, 85 %). Rf = 
0.25 in 6:1 Hex:EtOAc. 
FTIR (ATR): 3370 (br), 3085 (w), 2934, 2836 (w), 1640, 1611 (w), 1586, 1511, 
1459, 1441 (w), 1302, 1243, 1173 (s), 994, 909 (s), 830 (m) cm-1. 
1H NMR (300 MHz, CDCl3):  7.27 (d, J = 8.9 Hz, 2H), 6.93 – 6.84 (d, J = 8.5 Hz, 
2H), 5.78 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.04 – 4.90 (m, 2H), 4.67 – 4.59 (m, 
1H), 3.81 (s, 3H), 2.07 (d, J = 6.7 Hz, 1H), 1.89 – 1.62 (m, 3H), 1.50 (dddd, J = 
12.6, 10.4, 7.5, 5.2 Hz, 1H), 1.37 (dddd, J = 13.2, 10.8, 7.8, 5.6 Hz, 1H) ppm. 
13C NMR (75 MHz, CDCl3):  159.1, 138.6, 136.9, 127.1, 114.6, 113.8, 74.1, 





Preparation of 4-(benzyloxy)benzaldehyde 
 
Notebook Reference: RDLB162 
To a 100 mL round bottom flask with stir bar was charged with K2CO3 
(6.190 g, 50.00 mmol). Acetone (50 mL) was added followed by p-
hydroxybenzaldehyde (3.053 g, 25.00 mmol) and benzyl bromide (3.00 mL, 27.5 
mmol). The reaction was fitted with a condenser, refluxed overnight, and TLC 
showed complete consumption of starting material. Reaction concentrated in 
vacuo. The crude mixture was diluted with EtOAc, washed with saturated K2CO, 
washed with brine, dried MgSO4 and concentrated in vacuo to yield the product 
6-17 as a white solid (4.56 g, 21.5 mmol, 86 %) with no further purification 
necessary. 
FTIR (ATR): 3057 (w), 2829 (w), 2745 (w), 1686 (s), 1598, 1574, 1509, 1462, 
1452 (m), 1321, 1301, 1252, 1213 (m) cm-1.  
1HNMR (500 MHz, CDCl3):  9.89 (s, 1H), 7.88 – 7.81 (m, 2H), 7.47 – 7.30 (m, 
5H), 7.26 (s, 1H), 7.12 – 7.05 (m, 2H), 5.16 (s, 2H) ppm. 
13C NMR (75 MHz, CDCl3):  215.2, 190.8, 163.7, 135.9, 132.0, 130.1, 128.7, 
128.3, 127.5, 115.1, 70.3, 16.2 ppm.  
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Preparation of 1-(4-(benzyloxy)phenyl)prop-2-en-1-ol 
 
Notebook Reference: RDLB176, RDLB104 
To oven dried 100 mL 2-neck round bottom flask with stir bar and addition 
funnel was charged substrate 6-17 (4.132 g, 19.46 mmol), and placed under 
argon. THF (40 mL) was added via syringe, and the reaction vessel was cooled 
to -78 ˚C. Vinyl magnesium bromide (1M in THF, 23.35 mL) was added drop wise 
over 10 minutes. The reaction was warmed to 0 ˚C and stirred for 1 hour after 
which TLC indicated complete conversion of starting material. NH4Cl (40 mL) 
was added dropwise, extracted with EtOAc, washed with brine, dried with 
MgSO4, and concentrated in vacuo. The crude product was purified by column 
chromatography (75 mm, 6:1-3:1 Hex:EtOAc) to yield the desired product 6-18 
as a white solid (4.0511 g, 16.86 mmol, 87 - 91 %). Rf = 0.17 in 6:1 Hex:EtOAc. 
FTIR (ATR): 3320 (br), 3068, 3031 (w), 2910 (w), 2867 (w), 1611, 1585, 1509, 
1470, 1454, 1421, 1376 (m), 1318, 1302, 1244, 1194 (m), 987, 916 (s) cm-1.  
1HNMR (300 MHz, CDCl3):  7.50 – 7.32 (m, 4H), 7.40 – 7.14 (m, 3H), 7.07 – 
6.86 (m, 2H), 6.15 – 5.95 (m, 1H), 5.34 (dtd, J = 17.1, 1.4, 0.5 Hz, 1H), 5.28 – 
4.94 (m, 2H), 5.07 (s, 2H) ppm. 
13C NMR (75 MHz, CDCl3):  158.42, 140.32, 136.94, 135.09, 128.58, 127.95, 





Preparation of 1-(4-(benzyloxy)phenyl)allyl acetate 
 
Notebook Reference: RDLB184 
To a flame dried 50 mL tube with stir bar was charge substrate 6-18 
(1.201 g, 5.00 mmol) and placed under argon. DCM (20 ml) was added via 
syringe, and DMAP (1.466 g, 12.00 mmol) was added, followed by acetic 
anhydride (0.57 mL, 6.0 mmol). The reaction was refluxed for 1 hour upon which 
complete consumption of the starting material was observed. The organics were 
washed with 10 % HCl, then NaHC2O3, dried MgSO4, and concentrated in vacuo. 
The crude product was purified by column chromatography (40 mm, 12: 
Hex:EtOAc) to yield the intended product as a colorless amorphous solid (678.2 
mg, 2.402 mmol, 48 %). Rf = 0.32 in 6:1 Hex:EtOAc. 
FTIR (ATR): 3035 (w), 2934 (w), 1735 (s), 1645, 1610, 1586, 1513, 1466, 1454, 
1418 (m), 1386, 1367, 1300, 1227, 1176 (m), 992, 908 (s) cm-1.  
1HNMR (300 MHz, CDCl3):  7.49 – 7.23 (m, 6H), 7.32 – 7.20 (m, 1H), 7.06 – 
6.89 (m, 2H), 6.23 (d, J = 5.7 Hz, 1H), 6.00 (dddd, J = 17.0, 10.4, 5.7, 0.7 Hz, 
1H), 5.36 – 5.17 (m, 2H), 5.06 (s, 2H), 2.09 (s, 3H) ppm. 
13C NMR (75 MHz, CDCl3):  170.01, 136.84, 136.33, 131.26, 128.70, 128.58, 







Notebook Reference: RDLB186 
To an oven dried 2-neck 25 mL round bottom flask with stir bar was 
charged Grubbs 2nd generation catalyst (20.4 mg, 0.02402 mmol) and p-
benzoquinone (13.0 mg, 0.1201 mmol), and placed under argon. DCM (8 mL) 
was added to a mixture of substrate 6-12 (247.8 mg, 1.201 mmol) and 6-19 
(678.2 mg, 2.402 mmol) and added to the flask via syringe. The flask was fitted 
with a reflux condenser and the reaction was heated with an oil bath at 40 ˚C 
overnight. TLC indicated presence of products. The reaction mixture was pass 
through a plug of silica and rinsed with EtOAc, and concentrated in vacuo. The 
crude product was purified by column chromatography (40 mm, 6:1-3:1 
Hex:EtOAc). Two fractions were collected. Starting material 6-12 was collected in 
fraction 1 (348.6 mg, 1.945 mmol, 81 % recovery). Starting material 6-19 was 
collected in fraction 2 (100.7 mg, 0.4881 mmol, 41 % recovery). Acetone was 
rinsed through the column, and concentrated in vacuo. This was crude product 
was purified by column chromatography (40 mm, 3:1-2:1 Hex:EtOAc) to yield the 
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intended product 6-20 as a viscous oil (65.9 mg, 0.1431 mmol, 62 % reacted 
yield, 12 % overall yield).  
FTIR (ATR): 3435 (br), 3050 (w), 2855 (w), 1729 (s), 1606, 1509, 1454, 1371, 
1301 (w), 1238, 1174, 1018, 967 (s) cm-1.  
1HNMR (300 MHz, CDCl3):  7.46 – 7.19 (m, 9H), 7.01 – 6.83 (m, 4H), 6.56 – 
6.48 (m, 1H), 5.95 (ddd, J = 15.9, 7.6, 2.9 Hz, 1H), 5.36 (tt, J = 9.7, 4.8 Hz, 1H), 
5.07 (s, 2H), 4.65 – 4.58 (m, 1H), 3.80 (t, J = 2.6 Hz, 3H), 2.04 (s, 3H), 1.84 – 
1.71 (m, 1H), 1.34 (dtt, J = 19.3, 9.8, 5.1 Hz, 1H), 1.26 (s, 1H) ppm. 
13C NMR (75 MHz, CDCl3):  170.38, 159.07, 159.00, 158.63, 136.84, 136.79, 
136.77, 132.28, 132.19, 130.29, 129.30, 128.57, 127.97, 127.80, 127.41, 127.12, 
127.07, 125.47, 125.42, 114.92, 113.85, 113.80, 77.20, 74.85, 74.81, 74.15, 
74.02, 74.00, 70.01, 55.27, 38.55, 38.38, 34.42, 32.32, 29.69, 25.73, 21.63, 




Au(III)-Catalyzed Cyclization of (E)-1-(4-(benzyloxy)phenyl)-7-(4-
methoxyphenyl)hept-2-ene-1,7-diol 
 
Notebook Reference: RDLB192 
To 5 mL scintillation vial AuCl3 (0.4 mg, 0.001 mmol), AgOTf (1.0 mg, 
0.00375 mmol), and MS 4 Å (3.3 mg, 20% w/w). The reaction was placed under 
argon and Anhydrous DCM (0.2 mL) was added via syringe. The catalyst was 
allowed to form over 30 minutes. Substrate 6-20 (57.4 mg, 0.125 mmol) was 
diluted in DCM (0.3 mL) and added via syringe. Reaction changed to purple color 
in less than 1 minute, and TLC taken indicated complete consumption of starting 
material. Reaction was passed through a plug of silica, rinsed DCM, and 
concentrated in vacuo. The crude product was purified by column 
chromatography (15:1-9:1 Hex:EtOAc) to yield the desired product 6-21 as a 
colorless solid (41.3 mg, 0.103 mmol, 82 %).  
FTIR (ATR): 2924 (w), 2854 (w), 1725, 1607, 1511, 1455 (w), 1246, 1174, 1124, 
1074 (m) cm-1.  
1HNMR (500 MHz, CDCl3): 7.72 (dq, J = 4.5, 2.4 Hz, 2H), 7.53 (dd, J = 5.9, 3.3 
Hz, 2H), 7.46 – 7.37 (m, 2H), 7.42 – 7.28 (m, 3H), 6.96 – 6.84 (m, 4H), 6.57 (dd, 
J = 16.0, 1.2 Hz, 1H), 6.17 (dd, J = 16.0, 6.0 Hz, 1H), 5.06 (s, 2H), 4.43 (dd, J = 
11.3, 2.1 Hz, 1H), 4.31 (dq, J = 10.6, 7.3 Hz, 2H), 4.22 – 4.13 (m, 1H), 3.80 (s, 
2H), 2.00 (dt, J = 10.1, 3.8 Hz, 1H), 1.86 – 1.66 (m, 4H), 1.66 – 1.44 (m, 2H), 
1.26 (s, 10H), 1.03 – 0.74 (m, 8H) ppm. 
13C NMR (125 MHz, CDCl3):  167.67, 158.84, 158.25, 136.96, 135.58, 130.88, 
130.14, 129.21, 129.00, 128.80, 128.54, 127.92, 127.60, 127.44, 127.27, 114.82, 
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